Cluster Information | Plasmid Cluster ID | C1077 |
Reference Plasmid | NZ_CP104448.1 | |
Reference Plasmid Size | 4092895 | |
Reference Plasmid GC Content | 0.39 | |
Reference Plasmid Mobility Type | mobilizable |
mutid | gname | pos | count | tissue | frequnt | biotype | consequence | impact | nucchange | aachange |
---|---|---|---|---|---|---|---|---|---|---|
M0106915 | ANNHBBDC_03835 | 3895634 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 621A>G | Leu207Leu |
M0106916 | ANNHBBDC_02555 | 2601121 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 144A>G | Ser48Ser |
M0106917 | ANNHBBDC_02555 | 2601523 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 546T>C | Cys182Cys |
M0106918 | ANNHBBDC_02551 | 2601709 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -3357T>A | None |
M0106919 | ANNHBBDC_02556 | 2602136 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 225C>T | Ile75Ile |
M0106920 | ANNHBBDC_02558 | 2603469 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -238A>G | None |
M0106921 | ANNHBBDC_02558 | 2603473 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -242C>T | None |
M0106922 | ANNHBBDC_02558 | 2603541 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -310C>T | None |
M0106923 | ANNHBBDC_02558 | 2603587 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -356T>C | None |
M0106924 | ANNHBBDC_02558 | 2603625 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -394T>A | None |
M0106925 | ANNHBBDC_02558 | 2603632 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -401A>G | None |
M0106926 | ANNHBBDC_02558 | 2603712 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -481C>T | None |
M0106927 | ANNHBBDC_02559 | 2603830 | 3 | Skin | 0.05 | protein_coding | missense_variant | MODERATE | 575T>C | Leu192Ser |
M0106928 | ANNHBBDC_02559 | 2603942 | 3 | Skin | 0.05 | protein_coding | missense_variant | MODERATE | 463C>T | Leu155Phe |
M0106929 | ANNHBBDC_02559 | 2604136 | 3 | Skin | 0.05 | protein_coding | missense_variant | MODERATE | 269C>A | Thr90Asn |
M0106930 | ANNHBBDC_02559 | 2604221 | 3 | Skin | 0.05 | protein_coding | missense_variant | MODERATE | 184G>A | Ala62Thr |
M0106931 | ANNHBBDC_02560 | 2604620 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 672G>T | Leu224Leu |
M0106932 | ANNHBBDC_02560 | 2604659 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 633C>A | Ser211Ser |
M0106933 | ANNHBBDC_02560 | 2604766 | 3 | Skin | 0.05 | protein_coding | missense_variant | MODERATE | 526A>C | Lys176Gln |
M0106934 | ANNHBBDC_02560 | 2604794 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 498G>T | Ser166Ser |
M0106935 | ANNHBBDC_02560 | 2604850 | 3 | Skin | 0.05 | protein_coding | missense_variant | MODERATE | 442A>G | Met148Val |
M0106936 | ANNHBBDC_02560 | 2604872 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 420C>T | Ile140Ile |
M0106937 | ANNHBBDC_02560 | 2604926 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 366T>C | Leu122Leu |
M0106938 | ANNHBBDC_02560 | 2605106 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 186C>T | Val62Val |
M0106939 | ANNHBBDC_02560 | 2605211 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 81G>T | Ala27Ala |
M0106940 | ANNHBBDC_02558 | 2605317 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -2086G>A | None |
M0106941 | ANNHBBDC_02558 | 2605323 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -2092A>G | None |
M0106942 | ANNHBBDC_02558 | 2605350 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -2119A>C | None |
M0106943 | ANNHBBDC_02561 | 2605536 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 1062T>C | Gly354Gly |
M0106944 | ANNHBBDC_02561 | 2605617 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 981T>C | Asp327Asp |
M0106945 | ANNHBBDC_02561 | 2605860 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 738T>C | Gly246Gly |
M0106946 | ANNHBBDC_02561 | 2605917 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 681A>G | Val227Val |
M0106947 | ANNHBBDC_02558 | 2606749 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -3518G>T | None |
M0106948 | ANNHBBDC_02562 | 2607074 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 117G>A | Pro39Pro |
M0106949 | ANNHBBDC_02562 | 2607125 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 168C>T | Phe56Phe |
M0106950 | ANNHBBDC_02562 | 2607335 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 378C>T | Ile126Ile |
M0106951 | ANNHBBDC_02562 | 2607389 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 432A>T | Ala144Ala |
M0106952 | ANNHBBDC_02562 | 2607653 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 696C>T | Thr232Thr |
M0106953 | ANNHBBDC_02562 | 2607662 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 705T>G | Gly235Gly |
M0106954 | ANNHBBDC_02562 | 2607797 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 840A>G | Lys280Lys |
M0106955 | ANNHBBDC_02563 | 2608297 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 852T>C | Ala284Ala |
M0106956 | ANNHBBDC_02563 | 2608423 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 726T>A | Thr242Thr |
M0106957 | ANNHBBDC_02563 | 2608981 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 168C>T | Arg56Arg |
M0106958 | ANNHBBDC_02563 | 2609005 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 144T>C | Asn48Asn |
M0106959 | ANNHBBDC_02563 | 2609032 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 117C>T | Ile39Ile |
M0106960 | ANNHBBDC_02563 | 2609035 | 4 | Skin | 0.07 | protein_coding | synonymous_variant | LOW | 114A>G | Ala38Ala |
M0106961 | ANNHBBDC_02564 | 2609319 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 75T>C | Asp25Asp |
M0106962 | ANNHBBDC_02564 | 2609397 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 153A>T | Arg51Arg |
M0106963 | ANNHBBDC_02564 | 2609536 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 292A>C | Arg98Arg |
M0106964 | ANNHBBDC_02564 | 2609571 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 327T>C | Ala109Ala |
M0106965 | ANNHBBDC_02564 | 2609869 | 4 | Skin | 0.07 | protein_coding | missense_variant | MODERATE | 625G>A | Val209Ile |
M0106966 | ANNHBBDC_02565 | 2610037 | 4 | Skin | 0.07 | protein_coding | missense_variant | MODERATE | 76A>G | Thr26Ala |
M0106967 | ANNHBBDC_02560 | 2610185 | 4 | Skin | 0.07 | protein_coding | upstream_gene_variant | MODIFIER | -4894G>T | None |
M0106968 | ANNHBBDC_02561 | 2610295 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -3698A>G | None |
M0106969 | ANNHBBDC_02562 | 2608091 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 1134T>C | Gly378Gly |
M0106970 | ANNHBBDC_02562 | 2608142 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 1185T>C | Val395Val |
M0106971 | ANNHBBDC_02562 | 2608163 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 1206C>G | Val402Val |
M0106972 | ANNHBBDC_02562 | 2608172 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 1215C>T | Leu405Leu |
M0106973 | ANNHBBDC_02562 | 2608176 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 1219C>T | Leu407Leu |
M0106974 | ANNHBBDC_02558 | 2608226 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -4995T>C | None |
M0106975 | ANNHBBDC_02558 | 2608231 | 3 | Skin | 0.05 | protein_coding | upstream_gene_variant | MODIFIER | -5000C>A | None |
M0106976 | ANNHBBDC_02563 | 2608267 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 882C>T | Ser294Ser |
M0106977 | ANNHBBDC_02563 | 2608270 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 879G>A | Leu293Leu |
M0106978 | ANNHBBDC_02563 | 2608366 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 783C>T | Ile261Ile |
M0106979 | ANNHBBDC_02563 | 2608540 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 609T>C | Val203Val |
M0106980 | ANNHBBDC_02563 | 2608681 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 468T>C | Ala156Ala |
M0106981 | ANNHBBDC_02563 | 2608735 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 414G>A | Leu138Leu |
M0106982 | ANNHBBDC_02563 | 2608792 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 357G>A | Arg119Arg |
M0106983 | ANNHBBDC_02563 | 2608798 | 3 | Skin | 0.05 | protein_coding | synonymous_variant | LOW | 351T>C | Gly117Gly |
Gene Name | vf_gene_id | vf_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | vf_category | gene_description | condition |
---|---|---|---|---|---|---|---|---|---|---|---|
ANNHBBDC_00060 | VFG050303 | Ata | 77.5 | 0 | 1 | 1820 | 0.893 | 0.9774 | Adherence | trimeric autotransporter adhesin Ata | experiment |
ANNHBBDC_00175 | VFG037547 | HemO cluster | 100 | 2.8e-48 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | experiment |
ANNHBBDC_00176 | VFG037537 | HemO cluster | 99.3 | 5.6e-83 | 1 | 146 | 1.0 | 1 | Nutritional/Metabolic factor | YbaN family protein | experiment |
ANNHBBDC_00177 | VFG037529 | HemO cluster | 99.5 | 5.2e-108 | 1 | 198 | 1.0 | 0.995 | Nutritional/Metabolic factor | biliverdin-producing heme oxygenase | experiment |
ANNHBBDC_00178 | VFG037521 | HemO cluster | 95.4 | 7.2e-157 | 1 | 306 | 1.0 | 1 | Nutritional/Metabolic factor | TonB family protein | experiment |
ANNHBBDC_00179 | VFG037513 | HemO cluster | 96.7 | 1.9e-279 | 9 | 496 | 0.9839 | 1 | Nutritional/Metabolic factor | porin family protein | experiment |
ANNHBBDC_00180 | VFG037505 | HemO cluster | 99.2 | 8.1e-141 | 1 | 263 | 1.0 | 1 | Nutritional/Metabolic factor | transferrin-binding protein-like solute binding protein | experiment |
ANNHBBDC_00181 | VFG037497 | HemO cluster | 98.2 | 0 | 24 | 1057 | 0.9782 | 1 | Nutritional/Metabolic factor | TonB-dependent receptor | experiment |
ANNHBBDC_00182 | VFG037490 | HemO cluster | 96.2 | 4.3e-179 | 1 | 338 | 1.0 | 1 | Nutritional/Metabolic factor | FecR domain-containing protein | experiment |
ANNHBBDC_00183 | VFG037482 | HemO cluster | 98.8 | 1.1e-94 | 17 | 189 | 0.9153 | 1 | Nutritional/Metabolic factor | sigma-70 family RNA polymerase sigma factor | experiment |
ANNHBBDC_00184 | VFG037470 | HemO cluster | 99 | 2.9e-171 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | experiment |
ANNHBBDC_00216 | VFG050386 | TFP | 99.7 | 1.6e-195 | 11 | 355 | 0.9718 | 1 | Adherence | type IV pilus twitching motility protein PilT | experiment |
ANNHBBDC_00217 | VFG050400 | TFP | 99.2 | 9.8e-209 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | experiment |
ANNHBBDC_00245 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
ANNHBBDC_00471 | VFG050670 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 1 | Adherence | methyl-accepting chemotaxis protein | experiment |
ANNHBBDC_00472 | VFG050655 | TFP | 100 | 5.2e-72 | 1 | 130 | 0.9924 | 0.7303 | Adherence | chemotaxis protein CheW | experiment |
ANNHBBDC_00473 | VFG050640 | TFP | 100 | 2.5e-65 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | experiment |
ANNHBBDC_00474 | VFG050625 | TFP | 100 | 1.2e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | experiment |
ANNHBBDC_00500 | VFG038176 | OmpA | 99.7 | 1.1e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | experiment |
ANNHBBDC_00501 | VFG050610 | TFP | 99.4 | 2.4e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
ANNHBBDC_00607 | VFG037203 | Phospholipase D | 99.6 | 7.19999999993757e-314 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | experiment |
ANNHBBDC_00794 | VFG050595 | TFP | 94.3 | 5.2e-70 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | experiment |
ANNHBBDC_00795 | VFG050581 | TFP | 98.1 | 3.6e-83 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | experiment |
ANNHBBDC_00796 | VFG050567 | TFP | 99.8 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | experiment |
ANNHBBDC_00797 | VFG050554 | TFP | 100 | 1.9e-145 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
ANNHBBDC_00798 | VFG050540 | TFP | 97.3 | 3.9e-180 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | experiment |
ANNHBBDC_00799 | VFG050527 | TFP | 98.4 | 1.5e-96 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | experiment |
ANNHBBDC_00800 | VFG050514 | TFP | 98.7 | 4.2e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
ANNHBBDC_00810 | VFG050443 | TFP | 94.5 | 2.7e-69 | 1 | 144 | 1.0 | 0.9931 | Adherence | pilin | experiment |
ANNHBBDC_00820 | VFG050372 | TFP | 99.9 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | experiment |
ANNHBBDC_00821 | VFG050357 | TFP | 97.7 | 2.2e-94 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | experiment |
ANNHBBDC_00822 | VFG050342 | TFP | 99.2 | 8.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | experiment |
ANNHBBDC_00823 | VFG050328 | TFP | 100 | 3.5e-118 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | experiment |
ANNHBBDC_00824 | VFG050313 | TFP | 99.7 | 2.6e-195 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | experiment |
ANNHBBDC_00972 | VFG037822 | LPS | 100 | 5.9e-172 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | experiment |
ANNHBBDC_01010 | VFG050912 | T6SS | 93.6 | 0 | 1 | 1074 | 0.953 | 0.9826 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
ANNHBBDC_01209 | VFG037852 | Capsule | 99.2 | 0 | 1 | 728 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis tyrosine autokinase | experiment |
ANNHBBDC_01210 | VFG037867 | Capsule | 100 | 7.1e-83 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | experiment |
ANNHBBDC_01211 | VFG037882 | Capsule | 100 | 9.4e-212 | 1 | 366 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis/export family protein | experiment |
ANNHBBDC_01212 | VFG037897 | Capsule | 99.8 | 1.4e-246 | 1 | 424 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | experiment |
ANNHBBDC_01213 | VFG037912 | Capsule | 99.7 | 4e-193 | 1 | 332 | 1.0 | 1 | Immune modulation | UDP-N-acetylglucosamine 4,6-dehydratase (inverting) | experiment |
ANNHBBDC_01214 | VFG037927 | Capsule | 100 | 5.4e-226 | 1 | 386 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine transaminase | experiment |
ANNHBBDC_01215 | VFG037942 | Capsule | 100 | 3.4e-135 | 1 | 230 | 1.0 | 1 | Immune modulation | pseudaminic acid cytidylyltransferase | experiment |
ANNHBBDC_01216 | VFG037957 | Capsule | 99.7 | 2.8e-205 | 1 | 348 | 1.0 | 0.9534 | Immune modulation | UDP-2,4-diacetamido-2,4, 6-trideoxy-beta-L-altropyranose hydrolase | experiment |
ANNHBBDC_01217 | VFG037972 | Capsule | 100 | 4.1e-101 | 1 | 171 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase | experiment |
ANNHBBDC_01218 | VFG037987 | Capsule | 100 | 9.6e-206 | 1 | 349 | 1.0 | 1 | Immune modulation | pseudaminic acid synthase | experiment |
ANNHBBDC_01219 | VFG038002 | Capsule | 100 | 8.9e-219 | 1 | 410 | 1.0 | 1 | Immune modulation | hypothetical protein | experiment |
ANNHBBDC_01220 | VFG038017 | Capsule | 100 | 5e-282 | 1 | 480 | 1.0 | 1 | Immune modulation | capsular polysaccharide synthesis protein | experiment |
ANNHBBDC_01222 | VFG038047 | Capsule | 100 | 9.4e-113 | 1 | 203 | 1.0 | 1 | Immune modulation | hypothetical protein | experiment |
ANNHBBDC_01223 | VFG038062 | Capsule | 100 | 2.5e-161 | 1 | 274 | 1.0 | 1 | Immune modulation | hypothetical protein | experiment |
ANNHBBDC_01225 | VFG038091 | Capsule | 100 | 1.1e-116 | 1 | 206 | 1.0 | 1 | Immune modulation | sugar transferase | experiment |
ANNHBBDC_01226 | VFG038105 | Capsule | 100 | 9.2e-162 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | experiment |
ANNHBBDC_01227 | VFG038119 | Capsule | 100 | 1.7e-249 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | experiment |
ANNHBBDC_01228 | VFG038132 | Capsule | 100 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | experiment |
ANNHBBDC_01229 | VFG038144 | Capsule | 99.1 | 4.6e-197 | 1 | 338 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | experiment |
ANNHBBDC_01230 | VFG038155 | Capsule | 99.1 | 4.2e-270 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | experiment |
ANNHBBDC_01269 | VFG038191 | Quorom sensing | 99.5 | 1.5e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | experiment |
ANNHBBDC_01271 | VFG038205 | Quorom sensing | 97.7 | 1.8e-122 | 1 | 218 | 1.0 | 0.916 | Biofilm | DNA-binding HTH domain-containing protein | experiment |
ANNHBBDC_01326 | VFG050499 | TFP | 99.7 | 4.4e-228 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | experiment |
ANNHBBDC_01395 | VFG050699 | TFP | 99.2 | 1.8e-268 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | experiment |
ANNHBBDC_01396 | VFG050685 | TFP | 99 | 1.9e-287 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | experiment |
ANNHBBDC_01398 | VFG038249 | PbpG | 99.7 | 4.1e-182 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | experiment |
ANNHBBDC_01428 | VFG050712 | T2SS | 100 | 3e-145 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | experiment |
ANNHBBDC_01430 | VFG050727 | T2SS | 99.2 | 7.7e-133 | 9 | 249 | 0.9679 | 0.8669 | Effector delivery system | general secretion pathway protein C | experiment |
ANNHBBDC_01431 | VFG050742 | T2SS | 92.8 | 0 | 1 | 756 | 1.0 | 0.9974 | Effector delivery system | general secretion pathway protein D | experiment |
ANNHBBDC_01439 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
ANNHBBDC_01489 | VFG050484 | TFP | 97.6 | 4.1e-162 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | experiment |
ANNHBBDC_01490 | VFG050470 | TFP | 99.8 | 1e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | experiment |
ANNHBBDC_01491 | VFG050457 | TFP | 99.3 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | experiment |
ANNHBBDC_01530 | VFG050787 | T2SS | 100 | 9e-216 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | experiment |
ANNHBBDC_01531 | VFG050802 | T2SS | 100 | 1.9e-107 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | experiment |
ANNHBBDC_01589 | VFG050428 | TFP | 98.9 | 4.5e-240 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
ANNHBBDC_01593 | VFG037777 | LPS | 98.6 | 1.5e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | experiment |
ANNHBBDC_01594 | VFG037762 | LPS | 98.7 | 7.2e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | experiment |
ANNHBBDC_01661 | VFG050414 | TFP | 100 | 3.8e-146 | 1 | 266 | 1.0 | 1 | Adherence | type IV pilus biogenesis/stability protein PilW | experiment |
ANNHBBDC_01754 | VFG050757 | T2SS | 99.8 | 6.8e-282 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | experiment |
ANNHBBDC_01841 | VFG038219 | BfmRS | 100 | 3.3e-133 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | experiment |
ANNHBBDC_01842 | VFG038234 | BfmRS | 99.8 | 3.70000000001458e-313 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | experiment |
ANNHBBDC_01960 | VFG037638 | Bap | 90.6 | 0 | 2653 | 4608 | 0.4245 | 0.9674 | Biofilm | biofilm-associated protein | experiment |
ANNHBBDC_01993 | VFG001855 | Hsp60 | 72.8 | 2.5e-221 | 1 | 543 | 0.9982 | 0.9891 | Adherence | Hsp60, 60K heat shock protein HtpB | experiment |
ANNHBBDC_02057 | VFG037747 | LPS | 100 | 3.4e-189 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | experiment |
ANNHBBDC_02223 | VFG037456 | Acinetobactin | 98.3 | 2.8e-163 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | experiment |
ANNHBBDC_02224 | VFG037442 | Acinetobactin | 95.4 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | experiment |
ANNHBBDC_02225 | VFG037428 | Acinetobactin | 95.4 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | experiment |
ANNHBBDC_02227 | VFG037414 | Acinetobactin | 99 | 4.3e-157 | 1 | 300 | 0.9585 | 0.974 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | experiment |
ANNHBBDC_02228 | VFG037400 | Acinetobactin | 98.7 | 4.9e-169 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | experiment |
ANNHBBDC_02229 | VFG037386 | Acinetobactin | 98.4 | 2.9e-143 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | experiment |
ANNHBBDC_02230 | VFG037372 | Acinetobactin | 98.8 | 2.1e-183 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | experiment |
ANNHBBDC_02231 | VFG037358 | Acinetobactin | 99.5 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | experiment |
ANNHBBDC_02232 | VFG037344 | Acinetobactin | 99.3 | 1.8e-262 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | experiment |
ANNHBBDC_02233 | VFG037330 | Acinetobactin | 96.2 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | experiment |
ANNHBBDC_02234 | VFG037316 | Acinetobactin | 98.5 | 1.30000000000245e-313 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | experiment |
ANNHBBDC_02235 | VFG037302 | Acinetobactin | 99.7 | 1e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | experiment |
ANNHBBDC_02236 | VFG037288 | Acinetobactin | 99.5 | 2.5e-231 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | experiment |
ANNHBBDC_02238 | VFG037274 | Acinetobactin | 96.8 | 1.1e-280 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
ANNHBBDC_02239 | VFG037260 | Acinetobactin | 98.9 | 4.1e-285 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
ANNHBBDC_02240 | VFG037246 | Acinetobactin | 98.4 | 1.6e-143 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | experiment |
ANNHBBDC_02241 | VFG037232 | Acinetobactin | 97.2 | 1.2e-138 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | experiment |
ANNHBBDC_02242 | VFG037218 | Acinetobactin | 99 | 4.8e-222 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | experiment |
ANNHBBDC_02466 | VFG037735 | AdeFGH efflux pump | 99.4 | 5.8e-262 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | experiment |
ANNHBBDC_02467 | VFG037720 | AdeFGH efflux pump | 99.5 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | experiment |
ANNHBBDC_02468 | VFG037705 | AdeFGH efflux pump | 99.5 | 2.3e-219 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | experiment |
ANNHBBDC_02485 | VFG050772 | T2SS | 99.8 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | experiment |
ANNHBBDC_02518 | VFG050874 | T2SS | 99.2 | 2.9e-216 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | experiment |
ANNHBBDC_02519 | VFG050889 | T2SS | 100 | 3.3e-81 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | experiment |
ANNHBBDC_02567 | VFG037560 | Csu fimbriae | 100 | 1.8e-96 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | experiment |
ANNHBBDC_02569 | VFG037586 | Csu fimbriae | 97.7 | 1.8e-93 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | experiment |
ANNHBBDC_02570 | VFG037599 | Csu fimbriae | 98.9 | 1.1e-153 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | experiment |
ANNHBBDC_02571 | VFG037612 | Csu fimbriae | 99.8 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | experiment |
ANNHBBDC_02572 | VFG037625 | Csu fimbriae | 99.1 | 2e-192 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | experiment |
ANNHBBDC_02624 | VFG037664 | PNAG | 99.2 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | experiment |
ANNHBBDC_02625 | VFG037678 | PNAG | 99.8 | 1.5e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | experiment |
ANNHBBDC_02626 | VFG037692 | PNAG | 99.4 | 1.7e-85 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | experiment |
ANNHBBDC_02834 | VFG037177 | Phospholipase C | 98.8 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | experiment |
ANNHBBDC_02894 | VFG037837 | LPS | 99.4 | 1.7e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | experiment |
ANNHBBDC_02896 | VFG037792 | LPS | 100 | 8.6e-151 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | experiment |
ANNHBBDC_03261 | VFG037807 | LPS | 99.7 | 6.7e-224 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | experiment |
ANNHBBDC_03347 | VFG050860 | T2SS | 99.1 | 3.5e-178 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | experiment |
ANNHBBDC_03349 | VFG050832 | T2SS | 100 | 1.1e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | experiment |
ANNHBBDC_03350 | VFG050817 | T2SS | 100 | 4.4e-101 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | experiment |
ANNHBBDC_03655 | VFG050972 | T6SS | 100 | 1.3e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | experiment |
ANNHBBDC_03657 | VFG050946 | T6SS | 99.3 | 3.3e-150 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | experiment |
ANNHBBDC_03658 | VFG051028 | T6SS | 99.3 | 3.9e-260 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | experiment |
ANNHBBDC_03659 | VFG051084 | T6SS | 99.5 | 1.3e-210 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | experiment |
ANNHBBDC_03660 | VFG051098 | T6SS | 99.4 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | experiment |
ANNHBBDC_03664 | VFG050959 | T6SS | 99.6 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | experiment |
ANNHBBDC_03666 | VFG051014 | T6SS | 98.8 | 1.7e-191 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | experiment |
ANNHBBDC_03667 | VFG051000 | T6SS | 99.7 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | experiment |
ANNHBBDC_03668 | VFG050986 | T6SS | 100 | 4e-87 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | experiment |
ANNHBBDC_03669 | VFG051042 | T6SS | 100 | 8.6e-96 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | experiment |
ANNHBBDC_03670 | VFG051070 | T6SS | 100 | 2.4e-287 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | experiment |
ANNHBBDC_03671 | VFG051056 | T6SS | 100 | 5e-64 | 1 | 125 | 1.0 | 0.7485 | Effector delivery system | type VI secretion system contractile sheath small subunit | experiment |
ANNHBBDC_03708 | VFG050911 | T6SS | 92 | 0 | 1 | 1006 | 0.9491 | 0.9509 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
ANNHBBDC_03946 | VFG010906 | CsrA | 80 | 1.1e-19 | 1 | 55 | 0.6548 | 0.8594 | Regulation | carbon storage regulator CsrA | experiment |
BIMJNAPA_00060 | VFG050303 | Ata | 77.5 | 0 | 1 | 1820 | 0.893 | 0.9774 | Adherence | trimeric autotransporter adhesin Ata | experiment |
BIMJNAPA_00175 | VFG037547 | HemO cluster | 100 | 2.8e-48 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | experiment |
BIMJNAPA_00176 | VFG037537 | HemO cluster | 99.3 | 5.6e-83 | 1 | 146 | 1.0 | 1 | Nutritional/Metabolic factor | YbaN family protein | experiment |
BIMJNAPA_00177 | VFG037529 | HemO cluster | 99.5 | 5.2e-108 | 1 | 198 | 1.0 | 0.995 | Nutritional/Metabolic factor | biliverdin-producing heme oxygenase | experiment |
BIMJNAPA_00178 | VFG037521 | HemO cluster | 95.4 | 7.2e-157 | 1 | 306 | 1.0 | 1 | Nutritional/Metabolic factor | TonB family protein | experiment |
BIMJNAPA_00179 | VFG037513 | HemO cluster | 96.7 | 1.9e-279 | 9 | 496 | 0.9839 | 1 | Nutritional/Metabolic factor | porin family protein | experiment |
BIMJNAPA_00180 | VFG037505 | HemO cluster | 99.2 | 8.1e-141 | 1 | 263 | 1.0 | 1 | Nutritional/Metabolic factor | transferrin-binding protein-like solute binding protein | experiment |
BIMJNAPA_00181 | VFG037497 | HemO cluster | 98.2 | 0 | 24 | 1057 | 0.9782 | 1 | Nutritional/Metabolic factor | TonB-dependent receptor | experiment |
BIMJNAPA_00182 | VFG037490 | HemO cluster | 96.2 | 4.3e-179 | 1 | 338 | 1.0 | 1 | Nutritional/Metabolic factor | FecR domain-containing protein | experiment |
BIMJNAPA_00183 | VFG037482 | HemO cluster | 98.8 | 1.1e-94 | 17 | 189 | 0.9153 | 1 | Nutritional/Metabolic factor | sigma-70 family RNA polymerase sigma factor | experiment |
BIMJNAPA_00184 | VFG037470 | HemO cluster | 99 | 2.9e-171 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | experiment |
BIMJNAPA_00216 | VFG050386 | TFP | 99.7 | 1.6e-195 | 11 | 355 | 0.9718 | 1 | Adherence | type IV pilus twitching motility protein PilT | experiment |
BIMJNAPA_00217 | VFG050400 | TFP | 99.2 | 9.8e-209 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | experiment |
BIMJNAPA_00245 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
BIMJNAPA_00471 | VFG050670 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 1 | Adherence | methyl-accepting chemotaxis protein | experiment |
BIMJNAPA_00472 | VFG050655 | TFP | 100 | 5.2e-72 | 1 | 130 | 0.9924 | 0.7303 | Adherence | chemotaxis protein CheW | experiment |
BIMJNAPA_00473 | VFG050640 | TFP | 100 | 2.5e-65 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | experiment |
BIMJNAPA_00474 | VFG050625 | TFP | 100 | 1.2e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | experiment |
BIMJNAPA_00500 | VFG038176 | OmpA | 99.7 | 1.1e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | experiment |
BIMJNAPA_00501 | VFG050610 | TFP | 99.4 | 2.4e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
BIMJNAPA_00607 | VFG037203 | Phospholipase D | 99.6 | 7.19999999993757e-314 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | experiment |
BIMJNAPA_00794 | VFG050595 | TFP | 94.3 | 5.2e-70 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | experiment |
BIMJNAPA_00795 | VFG050581 | TFP | 98.1 | 3.6e-83 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | experiment |
BIMJNAPA_00796 | VFG050567 | TFP | 99.8 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | experiment |
BIMJNAPA_00797 | VFG050554 | TFP | 100 | 1.9e-145 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
BIMJNAPA_00798 | VFG050540 | TFP | 97.3 | 3.9e-180 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | experiment |
BIMJNAPA_00799 | VFG050527 | TFP | 98.4 | 1.5e-96 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | experiment |
BIMJNAPA_00800 | VFG050514 | TFP | 98.7 | 4.2e-76 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | experiment |
BIMJNAPA_00810 | VFG050443 | TFP | 94.5 | 2.7e-69 | 1 | 144 | 1.0 | 0.9931 | Adherence | pilin | experiment |
BIMJNAPA_00820 | VFG050372 | TFP | 99.9 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | experiment |
BIMJNAPA_00821 | VFG050357 | TFP | 97.7 | 2.2e-94 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | experiment |
BIMJNAPA_00822 | VFG050342 | TFP | 99.2 | 8.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | experiment |
BIMJNAPA_00823 | VFG050328 | TFP | 100 | 3.5e-118 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | experiment |
BIMJNAPA_00824 | VFG050313 | TFP | 99.7 | 2.6e-195 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | experiment |
BIMJNAPA_00972 | VFG037822 | LPS | 100 | 5.9e-172 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | experiment |
BIMJNAPA_01010 | VFG050912 | T6SS | 93.6 | 0 | 1 | 1074 | 0.953 | 0.9826 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
BIMJNAPA_01209 | VFG037852 | Capsule | 99.2 | 0 | 1 | 728 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis tyrosine autokinase | experiment |
BIMJNAPA_01210 | VFG037867 | Capsule | 100 | 7.1e-83 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | experiment |
BIMJNAPA_01211 | VFG037882 | Capsule | 100 | 9.4e-212 | 1 | 366 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis/export family protein | experiment |
BIMJNAPA_01212 | VFG037897 | Capsule | 99.8 | 1.4e-246 | 1 | 424 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | experiment |
BIMJNAPA_01213 | VFG037912 | Capsule | 99.7 | 4e-193 | 1 | 332 | 1.0 | 1 | Immune modulation | UDP-N-acetylglucosamine 4,6-dehydratase (inverting) | experiment |
BIMJNAPA_01214 | VFG037927 | Capsule | 100 | 5.4e-226 | 1 | 386 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine transaminase | experiment |
BIMJNAPA_01215 | VFG037942 | Capsule | 100 | 3.4e-135 | 1 | 230 | 1.0 | 1 | Immune modulation | pseudaminic acid cytidylyltransferase | experiment |
BIMJNAPA_01216 | VFG037957 | Capsule | 99.7 | 2.8e-205 | 1 | 348 | 1.0 | 0.9534 | Immune modulation | UDP-2,4-diacetamido-2,4, 6-trideoxy-beta-L-altropyranose hydrolase | experiment |
BIMJNAPA_01217 | VFG037972 | Capsule | 100 | 4.1e-101 | 1 | 171 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase | experiment |
BIMJNAPA_01218 | VFG037987 | Capsule | 100 | 9.6e-206 | 1 | 349 | 1.0 | 1 | Immune modulation | pseudaminic acid synthase | experiment |
BIMJNAPA_01219 | VFG038002 | Capsule | 100 | 8.9e-219 | 1 | 410 | 1.0 | 1 | Immune modulation | hypothetical protein | experiment |
BIMJNAPA_01220 | VFG038017 | Capsule | 100 | 5e-282 | 1 | 480 | 1.0 | 1 | Immune modulation | capsular polysaccharide synthesis protein | experiment |
BIMJNAPA_01222 | VFG038047 | Capsule | 100 | 9.4e-113 | 1 | 203 | 1.0 | 1 | Immune modulation | hypothetical protein | experiment |
BIMJNAPA_01223 | VFG038062 | Capsule | 100 | 2.5e-161 | 1 | 274 | 1.0 | 1 | Immune modulation | hypothetical protein | experiment |
BIMJNAPA_01225 | VFG038091 | Capsule | 100 | 1.1e-116 | 1 | 206 | 1.0 | 1 | Immune modulation | sugar transferase | experiment |
BIMJNAPA_01226 | VFG038105 | Capsule | 100 | 9.2e-162 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | experiment |
BIMJNAPA_01227 | VFG038119 | Capsule | 100 | 1.7e-249 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | experiment |
BIMJNAPA_01228 | VFG038132 | Capsule | 100 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | experiment |
BIMJNAPA_01229 | VFG038144 | Capsule | 99.1 | 4.6e-197 | 1 | 338 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | experiment |
BIMJNAPA_01230 | VFG038155 | Capsule | 99.1 | 4.2e-270 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | experiment |
BIMJNAPA_01269 | VFG038191 | Quorom sensing | 99.5 | 1.5e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | experiment |
BIMJNAPA_01271 | VFG038205 | Quorom sensing | 97.7 | 1.8e-122 | 1 | 218 | 1.0 | 0.916 | Biofilm | DNA-binding HTH domain-containing protein | experiment |
BIMJNAPA_01326 | VFG050499 | TFP | 99.7 | 4.4e-228 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | experiment |
BIMJNAPA_01395 | VFG050699 | TFP | 99.2 | 1.8e-268 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | experiment |
BIMJNAPA_01396 | VFG050685 | TFP | 99 | 1.9e-287 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | experiment |
BIMJNAPA_01398 | VFG038249 | PbpG | 99.7 | 4.1e-182 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | experiment |
BIMJNAPA_01428 | VFG050712 | T2SS | 100 | 3e-145 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | experiment |
BIMJNAPA_01430 | VFG050727 | T2SS | 99.2 | 7.7e-133 | 9 | 249 | 0.9679 | 0.8669 | Effector delivery system | general secretion pathway protein C | experiment |
BIMJNAPA_01431 | VFG050742 | T2SS | 92.8 | 0 | 1 | 756 | 1.0 | 0.9974 | Effector delivery system | general secretion pathway protein D | experiment |
BIMJNAPA_01439 | VFG046465 | EF-Tu | 78.2 | 2.6e-183 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | experiment |
BIMJNAPA_01489 | VFG050484 | TFP | 97.6 | 4.1e-162 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | experiment |
BIMJNAPA_01490 | VFG050470 | TFP | 99.8 | 1e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | experiment |
BIMJNAPA_01491 | VFG050457 | TFP | 99.3 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | experiment |
BIMJNAPA_01530 | VFG050787 | T2SS | 100 | 9e-216 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | experiment |
BIMJNAPA_01531 | VFG050802 | T2SS | 100 | 1.9e-107 | 1 | 193 | 1.0 | 1 | Effector delivery system | general secretion pathway protein G | experiment |
BIMJNAPA_01589 | VFG050428 | TFP | 98.9 | 4.5e-240 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | experiment |
BIMJNAPA_01593 | VFG037777 | LPS | 98.6 | 1.5e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | experiment |
BIMJNAPA_01594 | VFG037762 | LPS | 98.7 | 7.2e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | lauroyl acyltransferase | experiment |
BIMJNAPA_01661 | VFG050414 | TFP | 100 | 3.8e-146 | 1 | 266 | 1.0 | 1 | Adherence | type IV pilus biogenesis/stability protein PilW | experiment |
BIMJNAPA_01754 | VFG050757 | T2SS | 99.8 | 6.8e-282 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | experiment |
BIMJNAPA_01841 | VFG038219 | BfmRS | 100 | 3.3e-133 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | experiment |
BIMJNAPA_01842 | VFG038234 | BfmRS | 99.8 | 3.70000000001458e-313 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | experiment |
BIMJNAPA_01960 | VFG037638 | Bap | 90.6 | 0 | 2653 | 4608 | 0.4245 | 0.9674 | Biofilm | biofilm-associated protein | experiment |
BIMJNAPA_01993 | VFG001855 | Hsp60 | 72.8 | 2.5e-221 | 1 | 543 | 0.9982 | 0.9891 | Adherence | Hsp60, 60K heat shock protein HtpB | experiment |
BIMJNAPA_02057 | VFG037747 | LPS | 100 | 3.4e-189 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | experiment |
BIMJNAPA_02223 | VFG037456 | Acinetobactin | 98.3 | 2.8e-163 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | experiment |
BIMJNAPA_02224 | VFG037442 | Acinetobactin | 95.4 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | experiment |
BIMJNAPA_02225 | VFG037428 | Acinetobactin | 95.4 | 0 | 23 | 698 | 0.9685 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | experiment |
BIMJNAPA_02227 | VFG037414 | Acinetobactin | 99 | 4.3e-157 | 1 | 300 | 0.9585 | 0.974 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | experiment |
BIMJNAPA_02228 | VFG037400 | Acinetobactin | 98.7 | 4.9e-169 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | experiment |
BIMJNAPA_02229 | VFG037386 | Acinetobactin | 98.4 | 2.9e-143 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | experiment |
BIMJNAPA_02230 | VFG037372 | Acinetobactin | 98.8 | 2.1e-183 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | experiment |
BIMJNAPA_02231 | VFG037358 | Acinetobactin | 99.5 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | experiment |
BIMJNAPA_02232 | VFG037344 | Acinetobactin | 99.3 | 1.8e-262 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | experiment |
BIMJNAPA_02233 | VFG037330 | Acinetobactin | 96.2 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | experiment |
BIMJNAPA_02234 | VFG037316 | Acinetobactin | 98.5 | 1.30000000000245e-313 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | experiment |
BIMJNAPA_02235 | VFG037302 | Acinetobactin | 99.7 | 1e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | experiment |
BIMJNAPA_02236 | VFG037288 | Acinetobactin | 99.5 | 2.5e-231 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | experiment |
BIMJNAPA_02238 | VFG037274 | Acinetobactin | 96.8 | 1.1e-280 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
BIMJNAPA_02239 | VFG037260 | Acinetobactin | 98.9 | 4.1e-285 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | experiment |
BIMJNAPA_02240 | VFG037246 | Acinetobactin | 98.4 | 1.6e-143 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | experiment |
BIMJNAPA_02241 | VFG037232 | Acinetobactin | 97.2 | 1.2e-138 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | experiment |
BIMJNAPA_02242 | VFG037218 | Acinetobactin | 99 | 4.8e-222 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | experiment |
BIMJNAPA_02466 | VFG037735 | AdeFGH efflux pump | 99.4 | 5.8e-262 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | experiment |
BIMJNAPA_02467 | VFG037720 | AdeFGH efflux pump | 99.5 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | experiment |
BIMJNAPA_02468 | VFG037705 | AdeFGH efflux pump | 99.5 | 2.3e-219 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | experiment |
BIMJNAPA_02485 | VFG050772 | T2SS | 99.8 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | experiment |
BIMJNAPA_02518 | VFG050874 | T2SS | 99.2 | 2.9e-216 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | experiment |
BIMJNAPA_02519 | VFG050889 | T2SS | 100 | 3.3e-81 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | experiment |
BIMJNAPA_02567 | VFG037560 | Csu fimbriae | 100 | 1.8e-96 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | experiment |
BIMJNAPA_02569 | VFG037586 | Csu fimbriae | 97.7 | 1.8e-93 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | experiment |
BIMJNAPA_02570 | VFG037599 | Csu fimbriae | 98.9 | 1.1e-153 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | experiment |
BIMJNAPA_02571 | VFG037612 | Csu fimbriae | 99.8 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | experiment |
BIMJNAPA_02572 | VFG037625 | Csu fimbriae | 99.1 | 2e-192 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | experiment |
BIMJNAPA_02624 | VFG037664 | PNAG | 99.2 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | experiment |
BIMJNAPA_02625 | VFG037678 | PNAG | 99.8 | 1.5e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | experiment |
BIMJNAPA_02626 | VFG037692 | PNAG | 99.4 | 1.7e-85 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | experiment |
BIMJNAPA_02834 | VFG037177 | Phospholipase C | 98.8 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | experiment |
BIMJNAPA_02894 | VFG037837 | LPS | 99.4 | 1.7e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | experiment |
BIMJNAPA_02896 | VFG037792 | LPS | 100 | 8.6e-151 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | experiment |
BIMJNAPA_03261 | VFG037807 | LPS | 99.7 | 6.7e-224 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | experiment |
BIMJNAPA_03347 | VFG050860 | T2SS | 99.1 | 3.5e-178 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | experiment |
BIMJNAPA_03349 | VFG050832 | T2SS | 100 | 1.1e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | experiment |
BIMJNAPA_03350 | VFG050817 | T2SS | 100 | 4.4e-101 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | experiment |
BIMJNAPA_03655 | VFG050972 | T6SS | 100 | 1.3e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | experiment |
BIMJNAPA_03657 | VFG050946 | T6SS | 99.3 | 3.3e-150 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | experiment |
BIMJNAPA_03658 | VFG051028 | T6SS | 99.3 | 3.9e-260 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | experiment |
BIMJNAPA_03659 | VFG051084 | T6SS | 99.5 | 1.3e-210 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | experiment |
BIMJNAPA_03660 | VFG051098 | T6SS | 99.4 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | experiment |
BIMJNAPA_03664 | VFG050959 | T6SS | 99.6 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | experiment |
BIMJNAPA_03666 | VFG051014 | T6SS | 98.8 | 1.7e-191 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | experiment |
BIMJNAPA_03667 | VFG051000 | T6SS | 99.7 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | experiment |
BIMJNAPA_03668 | VFG050986 | T6SS | 100 | 4e-87 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | experiment |
BIMJNAPA_03669 | VFG051042 | T6SS | 100 | 8.6e-96 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | experiment |
BIMJNAPA_03670 | VFG051070 | T6SS | 100 | 2.4e-287 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | experiment |
BIMJNAPA_03671 | VFG051056 | T6SS | 100 | 5e-64 | 1 | 125 | 1.0 | 0.7485 | Effector delivery system | type VI secretion system contractile sheath small subunit | experiment |
BIMJNAPA_03708 | VFG050911 | T6SS | 92 | 0 | 1 | 1006 | 0.9491 | 0.9509 | Effector delivery system | type VI secretion system tip protein VgrG | experiment |
BIMJNAPA_03946 | VFG010906 | CsrA | 80 | 1.1e-19 | 1 | 55 | 0.6548 | 0.8594 | Regulation | carbon storage regulator CsrA | experiment |
ANNHBBDC_00060 | VFG050303 | Ata | 77.5 | 0 | 1 | 1820 | 0.893 | 0.9774 | Adherence | trimeric autotransporter adhesin Ata | prediction |
ANNHBBDC_00175 | VFG037547 | HemO cluster | 100 | 2.1e-47 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | prediction |
ANNHBBDC_00176 | VFG037537 | HemO cluster | 99.3 | 4.2e-82 | 1 | 146 | 1.0 | 1 | Nutritional/Metabolic factor | YbaN family protein | prediction |
ANNHBBDC_00177 | VFG037528 | HemO cluster | 100 | 1.3e-107 | 1 | 198 | 1.0 | 0.995 | Nutritional/Metabolic factor | biliverdin-producing heme oxygenase | prediction |
ANNHBBDC_00178 | VFG037522 | HemO cluster | 100 | 1.4e-164 | 1 | 306 | 1.0 | 1 | Nutritional/Metabolic factor | energy transducer TonB | prediction |
ANNHBBDC_00179 | VFG037512 | HemO cluster | 99 | 6.4e-284 | 9 | 496 | 0.9839 | 1 | Nutritional/Metabolic factor | porin family protein | prediction |
ANNHBBDC_00180 | VFG037506 | HemO cluster | 100 | 1.6e-140 | 1 | 263 | 1.0 | 1 | Nutritional/Metabolic factor | transferrin-binding protein-like solute binding protein | prediction |
ANNHBBDC_00181 | VFG037497 | HemO cluster | 98.2 | 0 | 24 | 1057 | 0.9782 | 1 | Nutritional/Metabolic factor | TonB-dependent receptor | prediction |
ANNHBBDC_00182 | VFG037491 | HemO cluster | 97.9 | 3.1e-181 | 1 | 338 | 1.0 | 1 | Nutritional/Metabolic factor | FecR domain-containing protein | prediction |
ANNHBBDC_00183 | VFG037482 | HemO cluster | 98.8 | 8e-94 | 17 | 189 | 0.9153 | 1 | Nutritional/Metabolic factor | sigma-70 family RNA polymerase sigma factor | prediction |
ANNHBBDC_00184 | VFG037470 | HemO cluster | 99 | 2.2e-170 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | prediction |
ANNHBBDC_00216 | VFG050395 | TFP | 99.7 | 1.1e-200 | 1 | 355 | 1.0 | 1 | Adherence | type IV pilus twitching motility protein PilT | prediction |
ANNHBBDC_00217 | VFG050398 | TFP | 99.5 | 3.3e-208 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | prediction |
ANNHBBDC_00245 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
ANNHBBDC_00471 | VFG050680 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 0.983 | Adherence | methyl-accepting chemotaxis protein | prediction |
ANNHBBDC_00472 | VFG050655 | TFP | 100 | 3.9e-71 | 1 | 130 | 0.9924 | 0.7303 | Adherence | chemotaxis protein CheW | prediction |
ANNHBBDC_00473 | VFG050640 | TFP | 100 | 1.9e-64 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | prediction |
ANNHBBDC_00474 | VFG050625 | TFP | 100 | 8.7e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | prediction |
ANNHBBDC_00500 | VFG038180 | OmpA | 99.7 | 4.9e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | prediction |
ANNHBBDC_00501 | VFG050608 | TFP | 100 | 4.7e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
ANNHBBDC_00607 | VFG037209 | Phospholipase D | 100 | 3.59999999996878e-314 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | prediction |
ANNHBBDC_00794 | VFG050601 | TFP | 97.9 | 3.8e-72 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | prediction |
ANNHBBDC_00795 | VFG050581 | TFP | 98.1 | 2.7e-82 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | prediction |
ANNHBBDC_00796 | VFG050571 | TFP | 99.7 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | prediction |
ANNHBBDC_00797 | VFG050554 | TFP | 100 | 1.4e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
ANNHBBDC_00798 | VFG050538 | TFP | 98.5 | 2.1e-182 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | prediction |
ANNHBBDC_00799 | VFG050527 | TFP | 98.4 | 1.1e-95 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | prediction |
ANNHBBDC_00800 | VFG050519 | TFP | 99.4 | 1.1e-75 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
ANNHBBDC_00810 | VFG050440 | TFP | 100 | 1.2e-73 | 1 | 144 | 1.0 | 1 | Adherence | pilin | prediction |
ANNHBBDC_00820 | VFG050372 | TFP | 99.9 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | prediction |
ANNHBBDC_00821 | VFG050355 | TFP | 99.4 | 8e-96 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | prediction |
ANNHBBDC_00822 | VFG050353 | TFP | 100 | 4.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | prediction |
ANNHBBDC_00823 | VFG050328 | TFP | 100 | 2.6e-117 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | prediction |
ANNHBBDC_00824 | VFG050321 | TFP | 100 | 6.8e-195 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | prediction |
ANNHBBDC_00972 | VFG037822 | LPS | 100 | 4.4e-171 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | prediction |
ANNHBBDC_01010 | VFG050922 | T6SS | 93.2 | 0 | 1 | 1113 | 0.9876 | 1.0063 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
ANNHBBDC_01209 | VFG037852 | Capsule | 99.2 | 0 | 1 | 728 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis tyrosine autokinase | prediction |
ANNHBBDC_01210 | VFG037867 | Capsule | 100 | 5.3e-82 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | prediction |
ANNHBBDC_01211 | VFG037882 | Capsule | 100 | 7e-211 | 1 | 366 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis/export family protein | prediction |
ANNHBBDC_01212 | VFG037897 | Capsule | 99.8 | 1e-245 | 1 | 424 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | prediction |
ANNHBBDC_01213 | VFG037912 | Capsule | 99.7 | 3e-192 | 1 | 332 | 1.0 | 1 | Immune modulation | UDP-N-acetylglucosamine 4,6-dehydratase (inverting) | prediction |
ANNHBBDC_01214 | VFG037927 | Capsule | 100 | 4e-225 | 1 | 386 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine transaminase | prediction |
ANNHBBDC_01215 | VFG037942 | Capsule | 100 | 2.5e-134 | 1 | 230 | 1.0 | 1 | Immune modulation | pseudaminic acid cytidylyltransferase | prediction |
ANNHBBDC_01216 | VFG037957 | Capsule | 99.7 | 2.1e-204 | 1 | 348 | 1.0 | 0.9534 | Immune modulation | UDP-2,4-diacetamido-2,4, 6-trideoxy-beta-L-altropyranose hydrolase | prediction |
ANNHBBDC_01217 | VFG037972 | Capsule | 100 | 3.1e-100 | 1 | 171 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase | prediction |
ANNHBBDC_01218 | VFG037987 | Capsule | 100 | 7.1e-205 | 1 | 349 | 1.0 | 1 | Immune modulation | pseudaminic acid synthase | prediction |
ANNHBBDC_01219 | VFG038002 | Capsule | 100 | 6.6e-218 | 1 | 410 | 1.0 | 1 | Immune modulation | hypothetical protein | prediction |
ANNHBBDC_01220 | VFG038017 | Capsule | 100 | 3.8e-281 | 1 | 480 | 1.0 | 1 | Immune modulation | capsular polysaccharide synthesis protein | prediction |
ANNHBBDC_01222 | VFG038047 | Capsule | 100 | 7e-112 | 1 | 203 | 1.0 | 1 | Immune modulation | hypothetical protein | prediction |
ANNHBBDC_01223 | VFG038062 | Capsule | 100 | 1.9e-160 | 1 | 274 | 1.0 | 1 | Immune modulation | hypothetical protein | prediction |
ANNHBBDC_01224 | VFG038088 | Capsule | 86.9 | 2.9e-140 | 4 | 277 | 0.9892 | 0.9964 | Immune modulation | glycosyltransferase | prediction |
ANNHBBDC_01225 | VFG038091 | Capsule | 100 | 8.2e-116 | 1 | 206 | 1.0 | 1 | Immune modulation | sugar transferase | prediction |
ANNHBBDC_01226 | VFG038105 | Capsule | 100 | 6.9e-161 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | prediction |
ANNHBBDC_01227 | VFG038119 | Capsule | 100 | 1.3e-248 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | prediction |
ANNHBBDC_01228 | VFG038132 | Capsule | 100 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | prediction |
ANNHBBDC_01229 | VFG038121 | Capsule | 100 | 1.4e-197 | 1 | 338 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | prediction |
ANNHBBDC_01230 | VFG038133 | Capsule | 100 | 1.5e-271 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | prediction |
ANNHBBDC_01269 | VFG038194 | Quorom sensing | 100 | 2.9e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | prediction |
ANNHBBDC_01271 | VFG038203 | Quorom sensing | 99.1 | 4.3e-123 | 1 | 218 | 1.0 | 0.916 | Biofilm | DNA-binding HTH domain-containing protein | prediction |
ANNHBBDC_01326 | VFG050502 | TFP | 100 | 2.5e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | prediction |
ANNHBBDC_01395 | VFG050699 | TFP | 99.2 | 1.4e-267 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | prediction |
ANNHBBDC_01396 | VFG050682 | TFP | 99.4 | 1.3e-287 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | prediction |
ANNHBBDC_01398 | VFG038249 | PbpG | 99.7 | 3.1e-181 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | prediction |
ANNHBBDC_01428 | VFG050712 | T2SS | 100 | 2.2e-144 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | prediction |
ANNHBBDC_01430 | VFG050725 | T2SS | 100 | 8e-134 | 9 | 249 | 0.9679 | 0.8669 | Effector delivery system | general secretion pathway protein C | prediction |
ANNHBBDC_01431 | VFG050751 | T2SS | 99.9 | 0 | 1 | 756 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | prediction |
ANNHBBDC_01439 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
ANNHBBDC_01489 | VFG050486 | TFP | 98.3 | 1.8e-161 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | prediction |
ANNHBBDC_01490 | VFG050470 | TFP | 99.8 | 7.8e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | prediction |
ANNHBBDC_01491 | VFG050461 | TFP | 99.8 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | prediction |
ANNHBBDC_01530 | VFG050787 | T2SS | 100 | 6.7e-215 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | prediction |
ANNHBBDC_01531 | VFG050812 | T2SS | 100 | 1.4e-106 | 1 | 193 | 1.0 | 0.9948 | Effector delivery system | general secretion pathway protein G | prediction |
ANNHBBDC_01589 | VFG050428 | TFP | 98.9 | 3.4e-239 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
ANNHBBDC_01593 | VFG037783 | LPS | 98.6 | 3.8e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | prediction |
ANNHBBDC_01594 | VFG037760 | LPS | 99.7 | 4.9e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | LpxL/LpxP family Kdo(2)-lipid IV(A) lauroyl/palmitoleoyl acyltransferase | prediction |
ANNHBBDC_01661 | VFG050414 | TFP | 100 | 2.8e-145 | 1 | 266 | 1.0 | 1 | Adherence | type IV pilus biogenesis/stability protein PilW | prediction |
ANNHBBDC_01754 | VFG050755 | T2SS | 100 | 1e-281 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | prediction |
ANNHBBDC_01841 | VFG038219 | BfmRS | 100 | 2.5e-132 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | prediction |
ANNHBBDC_01842 | VFG038234 | BfmRS | 99.8 | 2.79999999999768e-312 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | prediction |
ANNHBBDC_01960 | VFG037639 | Bap | 88.8 | 0 | 2504 | 4608 | 0.4568 | 1.0149 | Biofilm | biofilm-associated protein | prediction |
ANNHBBDC_01993 | VFG045692 | Hsp60 | 72.6 | 2.2e-221 | 1 | 543 | 0.9982 | 0.9855 | Adherence | Hsp60, 60K heat shock protein HtpB | prediction |
ANNHBBDC_02057 | VFG037747 | LPS | 100 | 2.6e-188 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | prediction |
ANNHBBDC_02181 | VFG044201 | Achromobactin biosynthesis and transport | 71.8 | 1.4e-187 | 13 | 455 | 0.9694 | 0.9672 | Nutritional/Metabolic factor | diaminobutyrate--2-oxoglutarate transaminase | prediction |
ANNHBBDC_02223 | VFG037454 | Acinetobactin | 98.6 | 9.5e-163 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | prediction |
ANNHBBDC_02224 | VFG037448 | Acinetobactin | 97.7 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | prediction |
ANNHBBDC_02225 | VFG037429 | Acinetobactin | 95.9 | 0 | 23 | 698 | 0.9685 | 1.0015 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | prediction |
ANNHBBDC_02227 | VFG037412 | Acinetobactin | 99.7 | 9.4e-164 | 1 | 313 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | prediction |
ANNHBBDC_02228 | VFG037400 | Acinetobactin | 98.7 | 3.7e-168 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | prediction |
ANNHBBDC_02229 | VFG037384 | Acinetobactin | 98.8 | 5.7e-143 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | prediction |
ANNHBBDC_02230 | VFG037370 | Acinetobactin | 99.4 | 1.1e-183 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | prediction |
ANNHBBDC_02231 | VFG037358 | Acinetobactin | 99.5 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | prediction |
ANNHBBDC_02232 | VFG037348 | Acinetobactin | 99.8 | 1.6e-262 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | prediction |
ANNHBBDC_02233 | VFG037329 | Acinetobactin | 96.8 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | prediction |
ANNHBBDC_02234 | VFG037320 | Acinetobactin | 99.1 | 3.59999999996878e-314 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | prediction |
ANNHBBDC_02235 | VFG037302 | Acinetobactin | 99.7 | 7.6e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | prediction |
ANNHBBDC_02236 | VFG037288 | Acinetobactin | 99.5 | 1.9e-230 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | prediction |
ANNHBBDC_02238 | VFG037273 | Acinetobactin | 98.7 | 4.1e-284 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
ANNHBBDC_02239 | VFG037260 | Acinetobactin | 98.9 | 3.1e-284 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
ANNHBBDC_02240 | VFG037252 | Acinetobactin | 98.8 | 7.1e-143 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | prediction |
ANNHBBDC_02241 | VFG037232 | Acinetobactin | 97.2 | 9.2e-138 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | prediction |
ANNHBBDC_02242 | VFG037218 | Acinetobactin | 99 | 3.6e-221 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | prediction |
ANNHBBDC_02466 | VFG037733 | AdeFGH efflux pump | 99.6 | 6.7e-262 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | prediction |
ANNHBBDC_02467 | VFG037720 | AdeFGH efflux pump | 99.5 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | prediction |
ANNHBBDC_02468 | VFG037705 | AdeFGH efflux pump | 99.5 | 1.7e-218 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | prediction |
ANNHBBDC_02485 | VFG050772 | T2SS | 99.8 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | prediction |
ANNHBBDC_02518 | VFG050872 | T2SS | 100 | 8.8e-217 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | prediction |
ANNHBBDC_02519 | VFG050889 | T2SS | 100 | 2.5e-80 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | prediction |
ANNHBBDC_02567 | VFG037560 | Csu fimbriae | 100 | 1.4e-95 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | prediction |
ANNHBBDC_02568 | VFG037571 | Csu fimbriae | 99.5 | 1.8e-98 | 1 | 182 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuA | prediction |
ANNHBBDC_02569 | VFG037592 | Csu fimbriae | 99.4 | 2.5e-94 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | prediction |
ANNHBBDC_02570 | VFG037605 | Csu fimbriae | 99.6 | 2.3e-153 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | prediction |
ANNHBBDC_02571 | VFG037612 | Csu fimbriae | 99.8 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | prediction |
ANNHBBDC_02572 | VFG037628 | Csu fimbriae | 99.4 | 3e-192 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | prediction |
ANNHBBDC_02623 | VFG037648 | PNAG | 99.5 | 0 | 1 | 812 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine export porin PgaA | prediction |
ANNHBBDC_02624 | VFG037664 | PNAG | 99.2 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | prediction |
ANNHBBDC_02625 | VFG037682 | PNAG | 100 | 8.4e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | prediction |
ANNHBBDC_02626 | VFG037692 | PNAG | 99.4 | 1.2e-84 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | prediction |
ANNHBBDC_02834 | VFG037177 | Phospholipase C | 98.8 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | prediction |
ANNHBBDC_02894 | VFG037836 | LPS | 99.7 | 4.4e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | prediction |
ANNHBBDC_02896 | VFG037792 | LPS | 100 | 6.4e-150 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | prediction |
ANNHBBDC_03261 | VFG037807 | LPS | 99.7 | 5e-223 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | prediction |
ANNHBBDC_03347 | VFG050857 | T2SS | 99.4 | 8.9e-178 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | prediction |
ANNHBBDC_03348 | VFG050844 | T2SS | 99.6 | 4e-127 | 1 | 233 | 1.0 | 1 | Effector delivery system | general secretion pathway protein J | prediction |
ANNHBBDC_03349 | VFG050832 | T2SS | 100 | 8.4e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | prediction |
ANNHBBDC_03350 | VFG050817 | T2SS | 100 | 3.3e-100 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | prediction |
ANNHBBDC_03655 | VFG050972 | T6SS | 100 | 9.4e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | prediction |
ANNHBBDC_03657 | VFG050944 | T6SS | 99.6 | 1.1e-149 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | prediction |
ANNHBBDC_03658 | VFG051026 | T6SS | 99.8 | 7e-261 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | prediction |
ANNHBBDC_03659 | VFG051084 | T6SS | 99.5 | 1e-209 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | prediction |
ANNHBBDC_03660 | VFG051100 | T6SS | 99.6 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | prediction |
ANNHBBDC_03664 | VFG050963 | T6SS | 99.8 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | prediction |
ANNHBBDC_03666 | VFG051014 | T6SS | 98.8 | 1.2e-190 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | prediction |
ANNHBBDC_03667 | VFG051000 | T6SS | 99.7 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | prediction |
ANNHBBDC_03668 | VFG050986 | T6SS | 100 | 3e-86 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | prediction |
ANNHBBDC_03669 | VFG051042 | T6SS | 100 | 6.4e-95 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | prediction |
ANNHBBDC_03670 | VFG051070 | T6SS | 100 | 1.8e-286 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | prediction |
ANNHBBDC_03671 | VFG051056 | T6SS | 100 | 3.7e-63 | 1 | 125 | 1.0 | 0.7485 | Effector delivery system | type VI secretion system contractile sheath small subunit | prediction |
ANNHBBDC_03708 | VFG050911 | T6SS | 92 | 0 | 1 | 1006 | 0.9491 | 0.9509 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
ANNHBBDC_03946 | VFG045727 | CsrA | 76.3 | 8.4e-19 | 1 | 59 | 0.7024 | 0.9219 | Regulation | carbon storage regulator CsrA | prediction |
BIMJNAPA_00060 | VFG050303 | Ata | 77.5 | 0 | 1 | 1820 | 0.893 | 0.9774 | Adherence | trimeric autotransporter adhesin Ata | prediction |
BIMJNAPA_00175 | VFG037547 | HemO cluster | 100 | 2.1e-47 | 1 | 91 | 1.0 | 1 | Nutritional/Metabolic factor | hypothetical protein | prediction |
BIMJNAPA_00176 | VFG037537 | HemO cluster | 99.3 | 4.2e-82 | 1 | 146 | 1.0 | 1 | Nutritional/Metabolic factor | YbaN family protein | prediction |
BIMJNAPA_00177 | VFG037528 | HemO cluster | 100 | 1.3e-107 | 1 | 198 | 1.0 | 0.995 | Nutritional/Metabolic factor | biliverdin-producing heme oxygenase | prediction |
BIMJNAPA_00178 | VFG037522 | HemO cluster | 100 | 1.4e-164 | 1 | 306 | 1.0 | 1 | Nutritional/Metabolic factor | energy transducer TonB | prediction |
BIMJNAPA_00179 | VFG037512 | HemO cluster | 99 | 6.4e-284 | 9 | 496 | 0.9839 | 1 | Nutritional/Metabolic factor | porin family protein | prediction |
BIMJNAPA_00180 | VFG037506 | HemO cluster | 100 | 1.6e-140 | 1 | 263 | 1.0 | 1 | Nutritional/Metabolic factor | transferrin-binding protein-like solute binding protein | prediction |
BIMJNAPA_00181 | VFG037497 | HemO cluster | 98.2 | 0 | 24 | 1057 | 0.9782 | 1 | Nutritional/Metabolic factor | TonB-dependent receptor | prediction |
BIMJNAPA_00182 | VFG037491 | HemO cluster | 97.9 | 3.1e-181 | 1 | 338 | 1.0 | 1 | Nutritional/Metabolic factor | FecR domain-containing protein | prediction |
BIMJNAPA_00183 | VFG037482 | HemO cluster | 98.8 | 8e-94 | 17 | 189 | 0.9153 | 1 | Nutritional/Metabolic factor | sigma-70 family RNA polymerase sigma factor | prediction |
BIMJNAPA_00184 | VFG037470 | HemO cluster | 99 | 2.2e-170 | 1 | 296 | 1.0 | 1 | Nutritional/Metabolic factor | LysR family transcriptional regulator | prediction |
BIMJNAPA_00216 | VFG050395 | TFP | 99.7 | 1.1e-200 | 1 | 355 | 1.0 | 1 | Adherence | type IV pilus twitching motility protein PilT | prediction |
BIMJNAPA_00217 | VFG050398 | TFP | 99.5 | 3.3e-208 | 1 | 372 | 1.0 | 1 | Adherence | PilT/PilU family type 4a pilus ATPase | prediction |
BIMJNAPA_00245 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
BIMJNAPA_00471 | VFG050680 | TFP | 99.9 | 0 | 1 | 692 | 1.0 | 0.983 | Adherence | methyl-accepting chemotaxis protein | prediction |
BIMJNAPA_00472 | VFG050655 | TFP | 100 | 3.9e-71 | 1 | 130 | 0.9924 | 0.7303 | Adherence | chemotaxis protein CheW | prediction |
BIMJNAPA_00473 | VFG050640 | TFP | 100 | 1.9e-64 | 1 | 120 | 1.0 | 1 | Adherence | response regulator | prediction |
BIMJNAPA_00474 | VFG050625 | TFP | 100 | 8.7e-68 | 1 | 127 | 1.0 | 1 | Adherence | twitching motility response regulator PilG | prediction |
BIMJNAPA_00500 | VFG038180 | OmpA | 99.7 | 4.9e-201 | 1 | 356 | 1.0 | 1 | Immune modulation | outer membrane protein OmpA | prediction |
BIMJNAPA_00501 | VFG050608 | TFP | 100 | 4.7e-93 | 1 | 171 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
BIMJNAPA_00607 | VFG037209 | Phospholipase D | 100 | 3.59999999996878e-314 | 1 | 541 | 1.0 | 1 | Exotoxin | phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase | prediction |
BIMJNAPA_00794 | VFG050601 | TFP | 97.9 | 3.8e-72 | 1 | 141 | 1.0 | 1 | Adherence | type IV pilin protein | prediction |
BIMJNAPA_00795 | VFG050581 | TFP | 98.1 | 2.7e-82 | 1 | 160 | 1.0 | 1 | Adherence | prepilin-type N-terminal cleavage/methylation domain-containing protein | prediction |
BIMJNAPA_00796 | VFG050571 | TFP | 99.7 | 0 | 5 | 1288 | 0.9969 | 1 | Adherence | VWA domain-containing protein | prediction |
BIMJNAPA_00797 | VFG050554 | TFP | 100 | 1.4e-144 | 1 | 272 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
BIMJNAPA_00798 | VFG050538 | TFP | 98.5 | 2.1e-182 | 1 | 333 | 1.0 | 1 | Adherence | PilW family protein | prediction |
BIMJNAPA_00799 | VFG050527 | TFP | 98.4 | 1.1e-95 | 1 | 184 | 1.0 | 0.9892 | Adherence | type IV pilus modification protein PilV | prediction |
BIMJNAPA_00800 | VFG050519 | TFP | 99.4 | 1.1e-75 | 1 | 157 | 1.0 | 1 | Adherence | GspH/FimT family pseudopilin | prediction |
BIMJNAPA_00810 | VFG050440 | TFP | 100 | 1.2e-73 | 1 | 144 | 1.0 | 1 | Adherence | pilin | prediction |
BIMJNAPA_00820 | VFG050372 | TFP | 99.9 | 0 | 1 | 721 | 1.0 | 1 | Adherence | type IV pilus secretin PilQ | prediction |
BIMJNAPA_00821 | VFG050355 | TFP | 99.4 | 8e-96 | 1 | 175 | 1.0 | 1 | Adherence | pilus assembly protein PilP | prediction |
BIMJNAPA_00822 | VFG050353 | TFP | 100 | 4.4e-132 | 1 | 246 | 1.0 | 1 | Adherence | type 4a pilus biogenesis protein PilO | prediction |
BIMJNAPA_00823 | VFG050328 | TFP | 100 | 2.6e-117 | 1 | 213 | 1.0 | 1 | Adherence | PilN domain-containing protein | prediction |
BIMJNAPA_00824 | VFG050321 | TFP | 100 | 6.8e-195 | 1 | 352 | 1.0 | 1 | Adherence | pilus assembly protein PilM | prediction |
BIMJNAPA_00972 | VFG037822 | LPS | 100 | 4.4e-171 | 1 | 300 | 1.0 | 1 | Immune modulation | UDP-3-O-acyl-N-acetylglucosamine deacetylase | prediction |
BIMJNAPA_01010 | VFG050922 | T6SS | 93.2 | 0 | 1 | 1113 | 0.9876 | 1.0063 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
BIMJNAPA_01209 | VFG037852 | Capsule | 99.2 | 0 | 1 | 728 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis tyrosine autokinase | prediction |
BIMJNAPA_01210 | VFG037867 | Capsule | 100 | 5.3e-82 | 1 | 142 | 1.0 | 1 | Immune modulation | low molecular weight phosphotyrosine protein phosphatase | prediction |
BIMJNAPA_01211 | VFG037882 | Capsule | 100 | 7e-211 | 1 | 366 | 1.0 | 1 | Immune modulation | polysaccharide biosynthesis/export family protein | prediction |
BIMJNAPA_01212 | VFG037897 | Capsule | 99.8 | 1e-245 | 1 | 424 | 1.0 | 1 | Immune modulation | Vi polysaccharide biosynthesis UDP-N-acetylglucosamine C-6 dehydrogenase TviB | prediction |
BIMJNAPA_01213 | VFG037912 | Capsule | 99.7 | 3e-192 | 1 | 332 | 1.0 | 1 | Immune modulation | UDP-N-acetylglucosamine 4,6-dehydratase (inverting) | prediction |
BIMJNAPA_01214 | VFG037927 | Capsule | 100 | 4e-225 | 1 | 386 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine transaminase | prediction |
BIMJNAPA_01215 | VFG037942 | Capsule | 100 | 2.5e-134 | 1 | 230 | 1.0 | 1 | Immune modulation | pseudaminic acid cytidylyltransferase | prediction |
BIMJNAPA_01216 | VFG037957 | Capsule | 99.7 | 2.1e-204 | 1 | 348 | 1.0 | 0.9534 | Immune modulation | UDP-2,4-diacetamido-2,4, 6-trideoxy-beta-L-altropyranose hydrolase | prediction |
BIMJNAPA_01217 | VFG037972 | Capsule | 100 | 3.1e-100 | 1 | 171 | 1.0 | 1 | Immune modulation | UDP-4-amino-4, 6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase | prediction |
BIMJNAPA_01218 | VFG037987 | Capsule | 100 | 7.1e-205 | 1 | 349 | 1.0 | 1 | Immune modulation | pseudaminic acid synthase | prediction |
BIMJNAPA_01219 | VFG038002 | Capsule | 100 | 6.6e-218 | 1 | 410 | 1.0 | 1 | Immune modulation | hypothetical protein | prediction |
BIMJNAPA_01220 | VFG038017 | Capsule | 100 | 3.8e-281 | 1 | 480 | 1.0 | 1 | Immune modulation | capsular polysaccharide synthesis protein | prediction |
BIMJNAPA_01222 | VFG038047 | Capsule | 100 | 7e-112 | 1 | 203 | 1.0 | 1 | Immune modulation | hypothetical protein | prediction |
BIMJNAPA_01223 | VFG038062 | Capsule | 100 | 1.9e-160 | 1 | 274 | 1.0 | 1 | Immune modulation | hypothetical protein | prediction |
BIMJNAPA_01224 | VFG038088 | Capsule | 86.9 | 2.9e-140 | 4 | 277 | 0.9892 | 0.9964 | Immune modulation | glycosyltransferase | prediction |
BIMJNAPA_01225 | VFG038091 | Capsule | 100 | 8.2e-116 | 1 | 206 | 1.0 | 1 | Immune modulation | sugar transferase | prediction |
BIMJNAPA_01226 | VFG038105 | Capsule | 100 | 6.9e-161 | 1 | 291 | 1.0 | 1 | Immune modulation | UTP--glucose-1-phosphate uridylyltransferase GalU | prediction |
BIMJNAPA_01227 | VFG038119 | Capsule | 100 | 1.3e-248 | 1 | 420 | 1.0 | 1 | Immune modulation | nucleotide sugar dehydrogenase | prediction |
BIMJNAPA_01228 | VFG038132 | Capsule | 100 | 0 | 1 | 556 | 1.0 | 1 | Immune modulation | glucose-6-phosphate isomerase | prediction |
BIMJNAPA_01229 | VFG038121 | Capsule | 100 | 1.4e-197 | 1 | 338 | 1.0 | 1 | Immune modulation | UDP-glucose 4-epimerase GalE | prediction |
BIMJNAPA_01230 | VFG038133 | Capsule | 100 | 1.5e-271 | 1 | 456 | 1.0 | 1 | Immune modulation | phosphomannomutase/phosphoglucomutase | prediction |
BIMJNAPA_01269 | VFG038194 | Quorom sensing | 100 | 2.9e-104 | 1 | 183 | 1.0 | 0.9734 | Biofilm | N-acyl-L-homoserine lactone synthetase | prediction |
BIMJNAPA_01271 | VFG038203 | Quorom sensing | 99.1 | 4.3e-123 | 1 | 218 | 1.0 | 0.916 | Biofilm | DNA-binding HTH domain-containing protein | prediction |
BIMJNAPA_01326 | VFG050502 | TFP | 100 | 2.5e-227 | 1 | 384 | 1.0 | 1 | Adherence | LysM peptidoglycan-binding domain-containing protein | prediction |
BIMJNAPA_01395 | VFG050699 | TFP | 99.2 | 1.4e-267 | 1 | 473 | 1.0 | 1 | Adherence | sigma-54 dependent transcriptional regulator | prediction |
BIMJNAPA_01396 | VFG050682 | TFP | 99.4 | 1.3e-287 | 1 | 522 | 1.0 | 1 | Adherence | PAS domain-containing sensor histidine kinase | prediction |
BIMJNAPA_01398 | VFG038249 | PbpG | 99.7 | 3.1e-181 | 1 | 335 | 1.0 | 0.9626 | Immune modulation | D-alanyl-D-alanine endopeptidase PBP7/8 | prediction |
BIMJNAPA_01428 | VFG050712 | T2SS | 100 | 2.2e-144 | 1 | 247 | 1.0 | 1 | Effector delivery system | type II secretion system protein N | prediction |
BIMJNAPA_01430 | VFG050725 | T2SS | 100 | 8e-134 | 9 | 249 | 0.9679 | 0.8669 | Effector delivery system | general secretion pathway protein C | prediction |
BIMJNAPA_01431 | VFG050751 | T2SS | 99.9 | 0 | 1 | 756 | 1.0 | 1 | Effector delivery system | general secretion pathway protein D | prediction |
BIMJNAPA_01439 | VFG046459 | EF-Tu | 79.2 | 2.7e-184 | 1 | 394 | 0.9949 | 1 | Adherence | elongation factor Tu | prediction |
BIMJNAPA_01489 | VFG050486 | TFP | 98.3 | 1.8e-161 | 1 | 286 | 1.0 | 1 | Adherence | A24 family peptidase | prediction |
BIMJNAPA_01490 | VFG050470 | TFP | 99.8 | 7.8e-219 | 1 | 408 | 1.0 | 1 | Adherence | type II secretion system F family protein | prediction |
BIMJNAPA_01491 | VFG050461 | TFP | 99.8 | 0 | 1 | 570 | 1.0 | 1 | Adherence | type IV-A pilus assembly ATPase PilB | prediction |
BIMJNAPA_01530 | VFG050787 | T2SS | 100 | 6.7e-215 | 1 | 401 | 1.0 | 1 | Effector delivery system | general secretion pathway protein F | prediction |
BIMJNAPA_01531 | VFG050812 | T2SS | 100 | 1.4e-106 | 1 | 193 | 1.0 | 0.9948 | Effector delivery system | general secretion pathway protein G | prediction |
BIMJNAPA_01589 | VFG050428 | TFP | 98.9 | 3.4e-239 | 1 | 454 | 1.0 | 1 | Adherence | hypothetical protein | prediction |
BIMJNAPA_01593 | VFG037783 | LPS | 98.6 | 3.8e-209 | 1 | 366 | 1.0 | 1 | Immune modulation | glycosyltransferase family 4 protein | prediction |
BIMJNAPA_01594 | VFG037760 | LPS | 99.7 | 4.9e-189 | 1 | 311 | 1.0 | 1 | Immune modulation | LpxL/LpxP family Kdo(2)-lipid IV(A) lauroyl/palmitoleoyl acyltransferase | prediction |
BIMJNAPA_01661 | VFG050414 | TFP | 100 | 2.8e-145 | 1 | 266 | 1.0 | 1 | Adherence | type IV pilus biogenesis/stability protein PilW | prediction |
BIMJNAPA_01754 | VFG050755 | T2SS | 100 | 1e-281 | 1 | 496 | 1.0 | 1 | Effector delivery system | general secretion pathway protein E | prediction |
BIMJNAPA_01841 | VFG038219 | BfmRS | 100 | 2.5e-132 | 1 | 238 | 1.0 | 1 | Regulation | biofilm-controlling response regulator | prediction |
BIMJNAPA_01842 | VFG038234 | BfmRS | 99.8 | 2.79999999999768e-312 | 1 | 549 | 1.0 | 1 | Regulation | signal transduction histidine kinase | prediction |
BIMJNAPA_01960 | VFG037639 | Bap | 88.8 | 0 | 2504 | 4608 | 0.4568 | 1.0149 | Biofilm | biofilm-associated protein | prediction |
BIMJNAPA_01993 | VFG045692 | Hsp60 | 72.6 | 2.2e-221 | 1 | 543 | 0.9982 | 0.9855 | Adherence | Hsp60, 60K heat shock protein HtpB | prediction |
BIMJNAPA_02057 | VFG037747 | LPS | 100 | 2.6e-188 | 1 | 327 | 1.0 | 1 | Immune modulation | lysophospholipid acyltransferase family protein | prediction |
BIMJNAPA_02181 | VFG044201 | Achromobactin biosynthesis and transport | 71.8 | 1.4e-187 | 13 | 455 | 0.9694 | 0.9672 | Nutritional/Metabolic factor | diaminobutyrate--2-oxoglutarate transaminase | prediction |
BIMJNAPA_02223 | VFG037454 | Acinetobactin | 98.6 | 9.5e-163 | 1 | 286 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore-interacting protein | prediction |
BIMJNAPA_02224 | VFG037448 | Acinetobactin | 97.7 | 0 | 1 | 615 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein | prediction |
BIMJNAPA_02225 | VFG037429 | Acinetobactin | 95.9 | 0 | 23 | 698 | 0.9685 | 1.0015 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains | prediction |
BIMJNAPA_02227 | VFG037412 | Acinetobactin | 99.7 | 9.4e-164 | 1 | 313 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauD | prediction |
BIMJNAPA_02228 | VFG037400 | Acinetobactin | 98.7 | 3.7e-168 | 1 | 315 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, permease protein BauC | prediction |
BIMJNAPA_02229 | VFG037384 | Acinetobactin | 98.8 | 5.7e-143 | 1 | 256 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, ATP-binding protein BauE | prediction |
BIMJNAPA_02230 | VFG037370 | Acinetobactin | 99.4 | 1.1e-183 | 1 | 322 | 1.0 | 1 | Nutritional/Metabolic factor | ferric siderophore ABC transporter, periplasmic siderophore-binding protein | prediction |
BIMJNAPA_02231 | VFG037358 | Acinetobactin | 99.5 | 0 | 1 | 751 | 1.0 | 0.9882 | Nutritional/Metabolic factor | TonB-dependent siderophore receptor BauA | prediction |
BIMJNAPA_02232 | VFG037348 | Acinetobactin | 99.8 | 1.6e-262 | 1 | 436 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasC | prediction |
BIMJNAPA_02233 | VFG037329 | Acinetobactin | 96.8 | 0 | 1 | 980 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasD | prediction |
BIMJNAPA_02234 | VFG037320 | Acinetobactin | 99.1 | 3.59999999996878e-314 | 1 | 542 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis | prediction |
BIMJNAPA_02235 | VFG037302 | Acinetobactin | 99.7 | 7.6e-168 | 1 | 289 | 1.0 | 1 | Nutritional/Metabolic factor | aryl carrier protein BasF | prediction |
BIMJNAPA_02236 | VFG037288 | Acinetobactin | 99.5 | 1.9e-230 | 1 | 383 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasF | prediction |
BIMJNAPA_02238 | VFG037273 | Acinetobactin | 98.7 | 4.1e-284 | 1 | 536 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
BIMJNAPA_02239 | VFG037260 | Acinetobactin | 98.9 | 3.1e-284 | 1 | 531 | 1.0 | 1 | Nutritional/Metabolic factor | siderophore efflux system of the ABC superfamily | prediction |
BIMJNAPA_02240 | VFG037252 | Acinetobactin | 98.8 | 7.1e-143 | 1 | 244 | 1.0 | 1 | Nutritional/Metabolic factor | non-ribosomal peptide biosynthesis thioesterase BasH | prediction |
BIMJNAPA_02241 | VFG037232 | Acinetobactin | 97.2 | 9.2e-138 | 1 | 251 | 1.0 | 1 | Nutritional/Metabolic factor | phosphopantetheinyl transferase component of acinetobactin biosynthesis protein BasI | prediction |
BIMJNAPA_02242 | VFG037218 | Acinetobactin | 99 | 3.6e-221 | 1 | 389 | 1.0 | 1 | Nutritional/Metabolic factor | acinetobactin biosynthesis protein BasJ | prediction |
BIMJNAPA_02466 | VFG037733 | AdeFGH efflux pump | 99.6 | 6.7e-262 | 1 | 482 | 1.0 | 1 | Biofilm | outer membrane protein | prediction |
BIMJNAPA_02467 | VFG037720 | AdeFGH efflux pump | 99.5 | 0 | 1 | 1059 | 1.0 | 1 | Biofilm | cation/multidrug efflux pump | prediction |
BIMJNAPA_02468 | VFG037705 | AdeFGH efflux pump | 99.5 | 1.7e-218 | 1 | 406 | 1.0 | 1 | Biofilm | membrane-fusion protein | prediction |
BIMJNAPA_02485 | VFG050772 | T2SS | 99.8 | 0 | 1 | 585 | 1.0 | 1 | Effector delivery system | putative secretion pathway ATPase | prediction |
BIMJNAPA_02518 | VFG050872 | T2SS | 100 | 8.8e-217 | 1 | 379 | 1.0 | 1 | Effector delivery system | general secretion pathway protein L | prediction |
BIMJNAPA_02519 | VFG050889 | T2SS | 100 | 2.5e-80 | 1 | 159 | 1.0 | 1 | Effector delivery system | general secretion pathway protein M | prediction |
BIMJNAPA_02567 | VFG037560 | Csu fimbriae | 100 | 1.4e-95 | 1 | 178 | 1.0 | 1 | Biofilm | Csu pilus major pilin subunit CsuA/B | prediction |
BIMJNAPA_02568 | VFG037571 | Csu fimbriae | 99.5 | 1.8e-98 | 1 | 182 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuA | prediction |
BIMJNAPA_02569 | VFG037592 | Csu fimbriae | 99.4 | 2.5e-94 | 1 | 172 | 1.0 | 1 | Biofilm | Csu pilus subunit CsuB | prediction |
BIMJNAPA_02570 | VFG037605 | Csu fimbriae | 99.6 | 2.3e-153 | 1 | 277 | 1.0 | 1 | Biofilm | Csu pilus chaperone protein CsuC | prediction |
BIMJNAPA_02571 | VFG037612 | Csu fimbriae | 99.8 | 0 | 1 | 832 | 1.0 | 1 | Biofilm | Csu pilus usher protein CsuD | prediction |
BIMJNAPA_02572 | VFG037628 | Csu fimbriae | 99.4 | 3e-192 | 1 | 339 | 1.0 | 1 | Biofilm | Csu pilus tip adhesin CsuE | prediction |
BIMJNAPA_02623 | VFG037648 | PNAG | 99.5 | 0 | 1 | 812 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine export porin PgaA | prediction |
BIMJNAPA_02624 | VFG037664 | PNAG | 99.2 | 0 | 1 | 609 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | prediction |
BIMJNAPA_02625 | VFG037682 | PNAG | 100 | 8.4e-245 | 1 | 415 | 1.0 | 1 | Biofilm | poly-beta-1,6 N-acetyl-D-glucosamine synthase | prediction |
BIMJNAPA_02626 | VFG037692 | PNAG | 99.4 | 1.2e-84 | 1 | 154 | 1.0 | 1 | Biofilm | poly-beta-1,6-N-acetyl-D-glucosamine biosynthesis protein PgaD | prediction |
BIMJNAPA_02834 | VFG037177 | Phospholipase C | 98.8 | 0 | 1 | 742 | 1.0 | 1 | Exotoxin | phospholipase C | prediction |
BIMJNAPA_02894 | VFG037836 | LPS | 99.7 | 4.4e-202 | 1 | 356 | 1.0 | 1 | Immune modulation | UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase | prediction |
BIMJNAPA_02896 | VFG037792 | LPS | 100 | 6.4e-150 | 1 | 262 | 1.0 | 1 | Immune modulation | acyl-ACP--UDP-N-acetylglucosamine O-acyltransferase | prediction |
BIMJNAPA_03261 | VFG037807 | LPS | 99.7 | 5e-223 | 1 | 391 | 1.0 | 1 | Immune modulation | lipid-A-disaccharide synthase | prediction |
BIMJNAPA_03347 | VFG050857 | T2SS | 99.4 | 8.9e-178 | 1 | 319 | 1.0 | 1 | Effector delivery system | general secretion pathway protein K | prediction |
BIMJNAPA_03348 | VFG050844 | T2SS | 99.6 | 4e-127 | 1 | 233 | 1.0 | 1 | Effector delivery system | general secretion pathway protein J | prediction |
BIMJNAPA_03349 | VFG050832 | T2SS | 100 | 8.4e-63 | 1 | 126 | 1.0 | 1 | Effector delivery system | general secretion pathway protein I | prediction |
BIMJNAPA_03350 | VFG050817 | T2SS | 100 | 3.3e-100 | 1 | 184 | 1.0 | 1 | Effector delivery system | general secretion pathway protein H | prediction |
BIMJNAPA_03655 | VFG050972 | T6SS | 100 | 9.4e-180 | 1 | 317 | 1.0 | 1 | Effector delivery system | type VI-associated gene X, peptidoglycan hydrolase | prediction |
BIMJNAPA_03657 | VFG050944 | T6SS | 99.6 | 1.1e-149 | 1 | 268 | 1.0 | 1 | Effector delivery system | type IVB secretion system protein TssL | prediction |
BIMJNAPA_03658 | VFG051026 | T6SS | 99.8 | 7e-261 | 1 | 454 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssK | prediction |
BIMJNAPA_03659 | VFG051084 | T6SS | 99.5 | 1e-209 | 1 | 364 | 1.0 | 1 | Effector delivery system | type VI secretion system protein TssA | prediction |
BIMJNAPA_03660 | VFG051100 | T6SS | 99.6 | 0 | 1 | 892 | 1.0 | 0.9989 | Effector delivery system | type VI secretion system ATPase TssH | prediction |
BIMJNAPA_03664 | VFG050963 | T6SS | 99.8 | 0 | 1 | 1274 | 1.0 | 1 | Effector delivery system | type VI secretion system membrane subunit TssM | prediction |
BIMJNAPA_03666 | VFG051014 | T6SS | 98.8 | 1.2e-190 | 1 | 332 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssG | prediction |
BIMJNAPA_03667 | VFG051000 | T6SS | 99.7 | 0 | 1 | 603 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssF | prediction |
BIMJNAPA_03668 | VFG050986 | T6SS | 100 | 3e-86 | 1 | 158 | 1.0 | 1 | Effector delivery system | type VI secretion system baseplate subunit TssE | prediction |
BIMJNAPA_03669 | VFG051042 | T6SS | 100 | 6.4e-95 | 1 | 167 | 1.0 | 1 | Effector delivery system | type VI secretion system tube protein Hcp | prediction |
BIMJNAPA_03670 | VFG051070 | T6SS | 100 | 1.8e-286 | 1 | 493 | 1.0 | 1 | Effector delivery system | type VI secretion system contractile sheath large subunit | prediction |
BIMJNAPA_03671 | VFG051056 | T6SS | 100 | 3.7e-63 | 1 | 125 | 1.0 | 0.7485 | Effector delivery system | type VI secretion system contractile sheath small subunit | prediction |
BIMJNAPA_03708 | VFG050911 | T6SS | 92 | 0 | 1 | 1006 | 0.9491 | 0.9509 | Effector delivery system | type VI secretion system tip protein VgrG | prediction |
BIMJNAPA_03946 | VFG045727 | CsrA | 76.3 | 8.4e-19 | 1 | 59 | 0.7024 | 0.9219 | Regulation | carbon storage regulator CsrA | prediction |
Gene Name | compound | identity | evalue | qstart | qend | query_coverage | subject_coverage | group |
---|---|---|---|---|---|---|---|---|
ANNHBBDC_00716 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.6 | 3.3e-139 | 91 | 328 | 0.7256 | 1.0000 | experiment |
ANNHBBDC_01067 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 1.1e-60 | 1 | 115 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_01416 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 99.3 | 1.5e-246 | 1 | 448 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_01554 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 100 | 5.5e-246 | 1 | 448 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_01734 | Cobalt (Co), Nickel (Ni) | 98.1 | 3.1e-235 | 1 | 416 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_01921 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3.5e-270 | 1 | 484 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_01922 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_01923 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-221 | 1 | 416 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_02079 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 71 | 9.2e-137 | 3 | 331 | 0.9910 | 0.9403 | experiment |
ANNHBBDC_02466 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.4 | 4.1e-263 | 1 | 482 | 1.0000 | 0.9979 | experiment |
ANNHBBDC_02467 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.5 | 0 | 1 | 1059 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_02468 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.5 | 3.6e-220 | 1 | 406 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_02477 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 4.1e-54 | 1 | 109 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_02832 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 99 | 4.2e-263 | 1 | 492 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_02882 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3e-128 | 1 | 217 | 1.0000 | 1.0000 | experiment |
ANNHBBDC_03081 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.3 | 1.2e-176 | 28 | 331 | 0.9184 | 1.0000 | experiment |
ANNHBBDC_03163 | Vanadium (V), Triclosan [class: Phenolic compounds] | 76.9 | 0 | 1 | 1019 | 0.9893 | 0.9903 | experiment |
BIMJNAPA_00716 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.6 | 3.3e-139 | 91 | 328 | 0.7256 | 1.0000 | experiment |
BIMJNAPA_01067 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 1.1e-60 | 1 | 115 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_01416 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 99.3 | 1.5e-246 | 1 | 448 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_01554 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 100 | 5.5e-246 | 1 | 448 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_01734 | Cobalt (Co), Nickel (Ni) | 98.1 | 3.1e-235 | 1 | 416 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_01921 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3.5e-270 | 1 | 484 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_01922 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_01923 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 1.5e-221 | 1 | 416 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_02079 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 71 | 9.2e-137 | 3 | 331 | 0.9910 | 0.9403 | experiment |
BIMJNAPA_02466 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.4 | 4.1e-263 | 1 | 482 | 1.0000 | 0.9979 | experiment |
BIMJNAPA_02467 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.5 | 0 | 1 | 1059 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_02468 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 99.5 | 3.6e-220 | 1 | 406 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_02477 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 4.1e-54 | 1 | 109 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_02832 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 99 | 4.2e-263 | 1 | 492 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_02882 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 3e-128 | 1 | 217 | 1.0000 | 1.0000 | experiment |
BIMJNAPA_03081 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 99.3 | 1.2e-176 | 28 | 331 | 0.9184 | 1.0000 | experiment |
BIMJNAPA_03163 | Vanadium (V), Triclosan [class: Phenolic compounds] | 76.9 | 0 | 1 | 1019 | 0.9893 | 0.9903 | experiment |
ANNHBBDC_00716 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-192 | 1 | 328 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_01127 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.1e-191 | 1 | 334 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_01128 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 84.5 | 8.2e-163 | 1 | 335 | 1.0030 | 1.0000 | prediction |
ANNHBBDC_01416 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 100 | 3e-245 | 1 | 448 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_01554 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 100 | 1.3e-243 | 1 | 448 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_01734 | Cobalt (Co), Nickel (Ni) | 100 | 3.1e-236 | 1 | 416 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_01921 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 8e-268 | 1 | 484 | 1.0000 | 0.9979 | prediction |
ANNHBBDC_01922 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 0 | 1 | 1058 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_01923 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 3.5e-219 | 1 | 416 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_02079 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 73.3 | 3.1e-138 | 3 | 330 | 0.9850 | 0.9400 | prediction |
ANNHBBDC_02466 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 2.2e-262 | 1 | 482 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_02467 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 0 | 1 | 1059 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_02468 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 2.6e-219 | 1 | 406 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_02477 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 9.5e-52 | 1 | 109 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_02832 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 100 | 2.3e-262 | 1 | 492 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_02882 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 6.8e-126 | 1 | 217 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_03081 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.6e-190 | 1 | 331 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_03160 | Methyl Viologen [class: Paraquat] | 76.8 | 2.3e-52 | 9 | 133 | 0.9398 | 0.8333 | prediction |
ANNHBBDC_03163 | Vanadium (V), Triclosan [class: Phenolic compounds] | 77 | 0 | 1 | 1019 | 0.9893 | 0.9903 | prediction |
ANNHBBDC_03173 | Arsenic (As) | 71.2 | 1.9e-87 | 9 | 248 | 0.9804 | 0.9881 | prediction |
ANNHBBDC_03205 | Chromium (Cr) | 93.9 | 3.8e-240 | 1 | 446 | 0.9933 | 0.9955 | prediction |
ANNHBBDC_03467 | Arsenic (As) | 100 | 4.2e-186 | 1 | 344 | 1.0000 | 1.0000 | prediction |
ANNHBBDC_03646 | Methyl Viologen [class: Paraquat] | 94.6 | 9e-77 | 1 | 149 | 0.9933 | 0.9933 | prediction |
ANNHBBDC_03825 | Copper (Cu), Gold (Au) | 71 | 0 | 5 | 821 | 0.9964 | 0.9915 | prediction |
BIMJNAPA_00716 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.7e-192 | 1 | 328 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_01127 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.1e-191 | 1 | 334 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_01128 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 84.5 | 8.2e-163 | 1 | 335 | 1.0030 | 1.0000 | prediction |
BIMJNAPA_01416 | Acriflavine [class: Acridine], Ethidium Bromide [class: Phenanthridine], Rhodamine 6G [class: Xanthene], Acridine Orange [class: Acridine], | 100 | 3e-245 | 1 | 448 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_01554 | 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Triclosan [class: Phenolic compounds], Acriflavine [class: Acridine], Hoechst 33342 [class: Bisbenzimide], Rhodamine 6G [class: Xanthene], Ethidium Bromide [class: Phenanthridine], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)] | 100 | 1.3e-243 | 1 | 448 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_01734 | Cobalt (Co), Nickel (Ni) | 100 | 3.1e-236 | 1 | 416 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_01921 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 8e-268 | 1 | 484 | 1.0000 | 0.9979 | prediction |
BIMJNAPA_01922 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 0 | 1 | 1058 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_01923 | Acridine Orange [class: Acridine], Safranin O [class: Azin], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Acriflavine [class: Acridine], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Chlorhexidine [class: Biguanides], Crystal Violet [class: Triarylmethane], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamidine], Sodium Deoxycholate (SDC) [class: Acid], Ethidium Bromide [class: Phenanthridine], Methyl Viologen [class: Paraquat], Rhodamine 123 [class: Xanthene], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Synergize [class: QAC-Glutaraldehyde], Virkon S [class: Peroxysulfate], Wex-cide-128 [class: Phenyl] | 100 | 3.5e-219 | 1 | 416 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_02079 | Chromium (Cr), Tellurium (Te), Selenium (Se) | 73.3 | 3.1e-138 | 3 | 330 | 0.9850 | 0.9400 | prediction |
BIMJNAPA_02466 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 2.2e-262 | 1 | 482 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_02467 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 0 | 1 | 1059 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_02468 | Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Ethidium Bromide [class: Phenanthridine], Safranin O [class: Azin], Acridine Orange [class: Acridine] | 100 | 2.6e-219 | 1 | 406 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_02477 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Pyronin Y [class: Xanthene], Rhodamine 6G [class: Xanthene], Methyl Viologen [class: Paraquat], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Crystal Violet [class: Triarylmethane], Cetrimide (CTM) [class: Quaternary Ammonium Compounds (QACs)], Cetylpyridinium Chloride (CPC) [class: Quaternary Ammonium Compounds (QACs)], Dequalinium [class: Quaternary Ammonium Compounds (QACs)] | 100 | 9.5e-52 | 1 | 109 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_02832 | Acriflavine [class: Acridine], Chlorhexidine [class: Biguanides], Methyl Viologen [class: Paraquat], Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Tetraphenylphosphonium (TPP) [class: Quaternary Ammonium Compounds (QACs)], Ethidium Bromide [class: Phenanthridine], Sodium Deoxycholate (SDC) [class: Acid] | 100 | 2.3e-262 | 1 | 492 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_02882 | Safranin O [class: Azin], Acridine Orange [class: Acridine], Pyronin Y [class: Xanthene], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate] | 100 | 6.8e-126 | 1 | 217 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_03081 | Benzylkonium Chloride (BAC) [class: Quaternary Ammonium Compounds (QACs)], Acriflavine [class: Acridine], Rhodamine 123 [class: Xanthene], Methyl Viologen [class: Paraquat], 4,6-diamidino-2-phenylindole (DAPI) [class: Diamindine], Acridine Orange [class: Acridine], Sodium Dodecyl Sulfate (SDS) [class: Organo-sulfate], Sodium Deoxycholate (SDC) [class: Acid], Synergize [class: QAC-Glutaraldehyde], Wex-cide-128 [class: Phenyl] | 100 | 1.6e-190 | 1 | 331 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_03160 | Methyl Viologen [class: Paraquat] | 76.8 | 2.3e-52 | 9 | 133 | 0.9398 | 0.8333 | prediction |
BIMJNAPA_03163 | Vanadium (V), Triclosan [class: Phenolic compounds] | 77 | 0 | 1 | 1019 | 0.9893 | 0.9903 | prediction |
BIMJNAPA_03173 | Arsenic (As) | 71.2 | 1.9e-87 | 9 | 248 | 0.9804 | 0.9881 | prediction |
BIMJNAPA_03205 | Chromium (Cr) | 93.9 | 3.8e-240 | 1 | 446 | 0.9933 | 0.9955 | prediction |
BIMJNAPA_03467 | Arsenic (As) | 100 | 4.2e-186 | 1 | 344 | 1.0000 | 1.0000 | prediction |
BIMJNAPA_03646 | Methyl Viologen [class: Paraquat] | 94.6 | 9e-77 | 1 | 149 | 0.9933 | 0.9933 | prediction |
BIMJNAPA_03825 | Copper (Cu), Gold (Au) | 71 | 0 | 5 | 821 | 0.9964 | 0.9915 | prediction |
Gene Name | aro_accession | identity | evalue | qstart | qend | query_coverage | subject_coverage | drug_class | amr_gene_family | resistance_mechanism |
---|---|---|---|---|---|---|---|---|---|---|
ANNHBBDC_00245 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
ANNHBBDC_00248 | ARO:3003395 | 71.5 | 5.38e-60 | 1 | 123 | 0.9919 | 0.9919 | aminoglycoside antibiotic | antibiotic-resistant rpsL | antibiotic target alteration |
ANNHBBDC_00411 | ARO:3002652 | 96.1 | 2.9e-180 | 1 | 259 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
ANNHBBDC_00705 | ARO:3003930 | 75 | 6.51e-49 | 1 | 100 | 0.9709 | 0.9709 | tetracycline antibiotic | tetracycline-resistant ribosomal protection protein | antibiotic target protection |
ANNHBBDC_00972 | ARO:3003574 | 100 | 1.6e-218 | 1 | 300 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
ANNHBBDC_01066 | ARO:3000410 | 100 | 2.94e-199 | 1 | 279 | 1.0000 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
ANNHBBDC_01067 | ARO:3005010 | 100 | 2.01e-78 | 1 | 115 | 1.0000 | 1.0000 | disinfecting agents and antiseptics | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_01068 | ARO:3001397 | 100 | 1.47e-206 | 1 | 275 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
ANNHBBDC_01069 | ARO:3002605 | 99.6 | 1.35e-191 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
ANNHBBDC_01070 | ARO:3000230 | 98.3 | 1.11e-132 | 1 | 177 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(2'') | antibiotic inactivation |
ANNHBBDC_01071 | ARO:3000873 | 100 | 5.12e-208 | 1 | 286 | 1.0000 | 1.0000 | monobactam | TEM beta-lactamase | antibiotic inactivation |
ANNHBBDC_01293 | ARO:3004089 | 98.1 | 1.19e-185 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
ANNHBBDC_01356 | ARO:3003818 | 99.9 | 0 | 1 | 739 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant parC | antibiotic target alteration |
ANNHBBDC_01361 | ARO:3003809 | 81.8 | 3.17e-262 | 1 | 438 | 1.0274 | 1.0321 | monobactam | Outer Membrane Porin (Opr) | reduced permeability to antibiotic |
ANNHBBDC_01416 | ARO:3004578 | 99.3 | 1.06e-300 | 1 | 448 | 1.0000 | 1.0000 | aminoglycoside antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_01439 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
ANNHBBDC_01447 | ARO:3003288 | 71 | 0 | 1 | 1359 | 1.0022 | 1.0171 | rifamycin antibiotic | rifamycin-resistant beta-subunit of RNA polymerase (rpoB) | antibiotic target alteration |
ANNHBBDC_01554 | ARO:3000753 | 100 | 5.40000000000001e-310 | 1 | 448 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | multidrug and toxic compound extrusion (MATE) transporter | antibiotic efflux |
ANNHBBDC_01593 | ARO:3005051 | 98.4 | 6.72e-267 | 1 | 366 | 1.0000 | 1.0000 | peptide antibiotic | Intrinsic peptide antibiotic resistant Lps | reduced permeability to antibiotic |
ANNHBBDC_01690 | ARO:3002652 | 96.1 | 2.9e-180 | 1 | 259 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
ANNHBBDC_01921 | ARO:3000782 | 100 | 0 | 1 | 484 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_01922 | ARO:3000781 | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_01923 | ARO:3000780 | 100 | 6.34e-279 | 1 | 416 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02040 | ARO:3003817 | 99.8 | 0 | 1 | 904 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant gyrA | antibiotic target alteration |
ANNHBBDC_02095 | ARO:3003808 | 77.9 | 3.42e-138 | 1 | 249 | 1.0000 | 1.0289 | carbapenem | CarO porin | reduced permeability to antibiotic |
ANNHBBDC_02248 | ARO:3003851 | 99.7 | 2.73e-286 | 1 | 383 | 1.0000 | 1.0000 | cephalosporin | ADC beta-lactamase without carbapenemase activity | antibiotic inactivation |
ANNHBBDC_02466 | ARO:3000779 | 99.6 | 0 | 2 | 482 | 0.9979 | 0.9959 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02467 | ARO:3000777 | 98.8 | 0 | 1 | 1059 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02468 | ARO:3000778 | 99.5 | 6.86e-278 | 1 | 406 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02477 | ARO:3000768 | 100 | 3.7e-69 | 1 | 109 | 1.0000 | 1.0000 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02832 | ARO:3004577 | 99 | 0 | 1 | 492 | 1.0000 | 1.0000 | macrolide antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02882 | ARO:3000559 | 99.1 | 4.36e-161 | 1 | 217 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_02896 | ARO:3003573 | 100 | 2.11e-126 | 1 | 262 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
ANNHBBDC_03082 | ARO:3000549 | 97.3 | 1.68e-230 | 14 | 341 | 0.9563 | 0.9086 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_03163 | ARO:3000808 | 76.9 | 0 | 1 | 1019 | 0.9893 | 0.9903 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_03168 | ARO:3000412 | 99.6 | 3.7e-185 | 12 | 282 | 0.9610 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
ANNHBBDC_03398 | ARO:3001614 | 100 | 3.45e-200 | 1 | 274 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
ANNHBBDC_03635 | ARO:3004573 | 99.8 | 7.07000000000002e-310 | 1 | 429 | 1.0000 | 1.0000 | phosphonic acid antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
ANNHBBDC_03946 | ARO:3005069 | 89.1 | 5.77e-28 | 1 | 55 | 0.6548 | 0.9016 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_00245 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
BIMJNAPA_00248 | ARO:3003395 | 71.5 | 5.38e-60 | 1 | 123 | 0.9919 | 0.9919 | aminoglycoside antibiotic | antibiotic-resistant rpsL | antibiotic target alteration |
BIMJNAPA_00411 | ARO:3002652 | 96.1 | 2.9e-180 | 1 | 259 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
BIMJNAPA_00705 | ARO:3003930 | 75 | 6.51e-49 | 1 | 100 | 0.9709 | 0.9709 | tetracycline antibiotic | tetracycline-resistant ribosomal protection protein | antibiotic target protection |
BIMJNAPA_00972 | ARO:3003574 | 100 | 1.6e-218 | 1 | 300 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
BIMJNAPA_01066 | ARO:3000410 | 100 | 2.94e-199 | 1 | 279 | 1.0000 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
BIMJNAPA_01067 | ARO:3005010 | 100 | 2.01e-78 | 1 | 115 | 1.0000 | 1.0000 | disinfecting agents and antiseptics | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_01068 | ARO:3001397 | 100 | 1.47e-206 | 1 | 275 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
BIMJNAPA_01069 | ARO:3002605 | 99.6 | 1.35e-191 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
BIMJNAPA_01070 | ARO:3000230 | 98.3 | 1.11e-132 | 1 | 177 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(2'') | antibiotic inactivation |
BIMJNAPA_01071 | ARO:3000873 | 100 | 5.12e-208 | 1 | 286 | 1.0000 | 1.0000 | monobactam | TEM beta-lactamase | antibiotic inactivation |
BIMJNAPA_01293 | ARO:3004089 | 98.1 | 1.19e-185 | 1 | 262 | 1.0000 | 1.0000 | aminoglycoside antibiotic | ANT(3'') | antibiotic inactivation |
BIMJNAPA_01356 | ARO:3003818 | 99.9 | 0 | 1 | 739 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant parC | antibiotic target alteration |
BIMJNAPA_01361 | ARO:3003809 | 81.8 | 3.17e-262 | 1 | 438 | 1.0274 | 1.0321 | monobactam | Outer Membrane Porin (Opr) | reduced permeability to antibiotic |
BIMJNAPA_01416 | ARO:3004578 | 99.3 | 1.06e-300 | 1 | 448 | 1.0000 | 1.0000 | aminoglycoside antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_01439 | ARO:3003368 | 85 | 3.03e-248 | 1 | 394 | 0.9949 | 1.0000 | elfamycin antibiotic | elfamycin resistant EF-Tu | antibiotic target alteration |
BIMJNAPA_01447 | ARO:3003288 | 71 | 0 | 1 | 1359 | 1.0022 | 1.0171 | rifamycin antibiotic | rifamycin-resistant beta-subunit of RNA polymerase (rpoB) | antibiotic target alteration |
BIMJNAPA_01554 | ARO:3000753 | 100 | 5.40000000000001e-310 | 1 | 448 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | multidrug and toxic compound extrusion (MATE) transporter | antibiotic efflux |
BIMJNAPA_01593 | ARO:3005051 | 98.4 | 6.72e-267 | 1 | 366 | 1.0000 | 1.0000 | peptide antibiotic | Intrinsic peptide antibiotic resistant Lps | reduced permeability to antibiotic |
BIMJNAPA_01690 | ARO:3002652 | 96.1 | 2.9e-180 | 1 | 259 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
BIMJNAPA_01921 | ARO:3000782 | 100 | 0 | 1 | 484 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_01922 | ARO:3000781 | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_01923 | ARO:3000780 | 100 | 6.34e-279 | 1 | 416 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02040 | ARO:3003817 | 99.8 | 0 | 1 | 904 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | fluoroquinolone resistant gyrA | antibiotic target alteration |
BIMJNAPA_02095 | ARO:3003808 | 77.9 | 3.42e-138 | 1 | 249 | 1.0000 | 1.0289 | carbapenem | CarO porin | reduced permeability to antibiotic |
BIMJNAPA_02248 | ARO:3003851 | 99.7 | 2.73e-286 | 1 | 383 | 1.0000 | 1.0000 | cephalosporin | ADC beta-lactamase without carbapenemase activity | antibiotic inactivation |
BIMJNAPA_02466 | ARO:3000779 | 99.6 | 0 | 2 | 482 | 0.9979 | 0.9959 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02467 | ARO:3000777 | 98.8 | 0 | 1 | 1059 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02468 | ARO:3000778 | 99.5 | 6.86e-278 | 1 | 406 | 1.0000 | 1.0000 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02477 | ARO:3000768 | 100 | 3.7e-69 | 1 | 109 | 1.0000 | 1.0000 | macrolide antibiotic | small multidrug resistance (SMR) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02832 | ARO:3004577 | 99 | 0 | 1 | 492 | 1.0000 | 1.0000 | macrolide antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02882 | ARO:3000559 | 99.1 | 4.36e-161 | 1 | 217 | 1.0000 | 1.0000 | macrolide antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_02896 | ARO:3003573 | 100 | 2.11e-126 | 1 | 262 | 1.0000 | 1.0000 | peptide antibiotic | Acinetobacter mutant Lpx gene conferring resistance to colistin | antibiotic target alteration |
BIMJNAPA_03082 | ARO:3000549 | 97.3 | 1.68e-230 | 14 | 341 | 0.9563 | 0.9086 | glycylcycline | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_03163 | ARO:3000808 | 76.9 | 0 | 1 | 1019 | 0.9893 | 0.9903 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_03168 | ARO:3000412 | 99.6 | 3.7e-185 | 12 | 282 | 0.9610 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
BIMJNAPA_03398 | ARO:3001614 | 100 | 3.45e-200 | 1 | 274 | 1.0000 | 1.0000 | carbapenem | OXA beta-lactamase | antibiotic inactivation |
BIMJNAPA_03635 | ARO:3004573 | 99.8 | 7.07000000000002e-310 | 1 | 429 | 1.0000 | 1.0000 | phosphonic acid antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
BIMJNAPA_03946 | ARO:3005069 | 89.1 | 5.77e-28 | 1 | 55 | 0.6548 | 0.9016 | fluoroquinolone antibiotic | resistance-nodulation-cell division (RND) antibiotic efflux pump | antibiotic efflux |
Gene Name | phi_molconn_id | host gene_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | host_descripton | disease_name | function | phenotype_of_mutant |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ANNHBBDC_00060 | PHI:9898 | ata | 76.9 | 0 | 1 | 1820 | 0.8930 | 0.9616 | primates | nosocomial infection | trimeric autotransporter adhesin | reduced virulence |
ANNHBBDC_00166 | PHI:7520 | VK055_1952 | 75.4 | 6e-213 | 8 | 490 | 0.9857 | 0.9918 | rodents | pneumonia | betaine aldehyde dehydrogenase | unaffected pathogenicity |
ANNHBBDC_00202 | PHI:10510 | ggt | 99.1 | 0 | 1 | 661 | 1.0000 | 1.0000 | rodents | nosocomial infection | gamma-glutamyltransferase | reduced virulence |
ANNHBBDC_00245 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
ANNHBBDC_00388 | PHI:11869 | otsB | 96.8 | 2.9e-159 | 1 | 283 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein B | unaffected pathogenicity |
ANNHBBDC_00392 | PHI:7809 | adeN | 99.9 | 0 | 1 | 678 | 1.0000 | 1.0000 | moths | nosocomial infection | TetR type regulator | increased virulence (hypervirulence) |
ANNHBBDC_00474 | PHI:10421 | PilG (XC_1183) | 75.8 | 2.9e-50 | 8 | 127 | 0.9449 | 0.9023 | eudicots | black rot | single domain response regulator | reduced virulence |
ANNHBBDC_00494 | PHI:11030 | bipA | 70.9 | 2.1e-247 | 4 | 607 | 0.9885 | 0.9852 | rodents | pneumonic plague | putative GTPase | reduced virulence |
ANNHBBDC_00500 | PHI:9283 | OmpA | 99.4 | 8.5e-201 | 1 | 356 | 1.0000 | 1.0000 | nematodes | pneumonia | outer membrane protein | reduced virulence |
ANNHBBDC_00520 | PHI:5240 | secA | 99.8 | 0 | 1 | 907 | 1.0000 | 1.0000 | moths | nosocomial infection | iron utilization | reduced virulence |
ANNHBBDC_00521 | PHI:3243 | lsfA | 79.7 | 2.3e-100 | 1 | 212 | 0.9953 | 1.0000 | rodents | opportunistic infection | 1-Cys peroxiredoxin with thioldependent peroxidase activity | reduced virulence |
ANNHBBDC_00548 | PHI:5094 | PLD3 | 98.6 | 9.3e-283 | 1 | 487 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
ANNHBBDC_00607 | PHI:5093 | PLD2 | 99.8 | 5.10000000016164e-314 | 1 | 541 | 1.0000 | 0.9963 | moths | nosocomial infection | phospholipases D | reduced virulence |
ANNHBBDC_00614 | PHI:10160 | ksgA | 100 | 2e-154 | 1 | 270 | 1.0000 | 1.0000 | nematodes | skin infection; soft tissue infection; urinary tract infection; meningitis; wound infection | 16S rRNA methyltransferase | reduced virulence |
ANNHBBDC_00694 | PHI:11120 | rplN | 74.6 | 3.2e-46 | 1 | 122 | 1.0000 | 1.0000 | primates | pertussis | 50S ribosomal protein | unaffected pathogenicity |
ANNHBBDC_00875 | PHI:10701 | hisF (A1S_3245) | 100 | 1.5e-143 | 1 | 252 | 1.0000 | 1.0000 | rodents | pneumonia | imidazole glycerol phosphate synthase cyclase subunit | reduced virulence |
ANNHBBDC_00972 | PHI:10612 | lpxC | 100 | 1.6e-171 | 1 | 300 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acyl-N-acetylglucosamine deacetylase | reduced virulence |
ANNHBBDC_01036 | PHI:8042 | lpxA | 99.8 | 9.7e-258 | 1 | 454 | 1.0000 | 1.0000 | rodents | pneumonia | N-acetylglucosamine-1-phosphate uridyltransferase | reduced virulence |
ANNHBBDC_01068 | PHI:123477 | Oxa-2 | 100 | 5.1e-161 | 1 | 275 | 1.0000 | 1.0000 | moths | nosocomial infection | beta-lactamase | reduced virulence |
ANNHBBDC_01209 | PHI:124392 | wzc | 95.6 | 0 | 1 | 728 | 1.0000 | 1.0000 | moths | nosocomial infection | multidrug-resistant factor | unaffected pathogenicity |
ANNHBBDC_01269 | PHI:8774 | abaI | 95.7 | 1.3e-99 | 1 | 183 | 1.0000 | 1.0000 | moths | nosocomial infection | acyl-homoserine-lactone synthase | reduced virulence |
ANNHBBDC_01270 | PHI:11261 | abaM (ABUW_3775) | 99.3 | 2.5e-76 | 1 | 138 | 1.0000 | 1.0000 | moths | nosocomial infection | DUF4902 domain-containing protein | reduced virulence |
ANNHBBDC_01329 | PHI:9117 | TonB-dependent copper receptor | 99.1 | 0 | 1 | 704 | 1.0000 | 1.0000 | rodents | nosocomial infection | TonB-dependent copper receptor, outer membraneprotein | reduced virulence |
ANNHBBDC_01361 | PHI:11092 | oprD | 99.5 | 9.7e-255 | 1 | 438 | 1.0000 | 1.0000 | rodents | pneumonia | outer membrane protein | reduced virulence |
ANNHBBDC_01397 | PHI:6601 | gacA | 100 | 8e-114 | 1 | 211 | 1.0000 | 1.0000 | bony fishes | bacteremia | response regulator | reduced virulence |
ANNHBBDC_01409 | PHI:11772 | dksA (AlS_0248 ) | 100 | 4.4e-97 | 1 | 178 | 1.0000 | 1.0000 | rodents | nosocomial infection | RNA polymerase-binding transcription factor | reduced virulence |
ANNHBBDC_01416 | PHI:4996 | AbuO | 99.3 | 2.4e-245 | 1 | 448 | 1.0000 | 1.0000 | nematodes | nosocomial infection | outer membrane protein | reduced virulence |
ANNHBBDC_01431 | PHI:123173 | gspD | 90.3 | 0 | 1 | 756 | 1.0000 | 1.0000 | rodents | urinary tract infection | type II secretion (T2S) system that is responsible for secretion of InvL | reduced virulence |
ANNHBBDC_01439 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
ANNHBBDC_01447 | PHI:7860 | RpoB | 99.8 | 0 | 1 | 1357 | 0.9963 | 1.0000 | nematodes | nosocomial infection | beta-subunit of the RNA polymerase | reduced virulence |
ANNHBBDC_01570 | PHI:6089 | katG | 96.1 | 0 | 1 | 718 | 1.0000 | 1.0000 | moths | bacteremia | catalase-peroxidase | increased virulence (hypervirulence) |
ANNHBBDC_01578 | PHI:9981 | leuC (PXO_02613) | 74.5 | 2.5e-209 | 38 | 507 | 0.9234 | 0.9751 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase large subunit | reduced virulence |
ANNHBBDC_01579 | PHI:9980 | leuD (PXO_02612) | 72.5 | 1.5e-91 | 1 | 211 | 0.9814 | 0.9814 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase small subunit | reduced virulence |
ANNHBBDC_01581 | PHI:9979 | leuB (PXO_02610) | 72.9 | 1.1e-144 | 1 | 358 | 0.9972 | 1.0000 | monocots | bacterial leaf blight | 3-isopropylmalate dehydrogenase | reduced virulence |
ANNHBBDC_01592 | PHI:124242 | gltP | 73.1 | 2.7e-169 | 1 | 424 | 0.9907 | 0.9703 | rodents | neonatal meningitis | glutamate transporters | reduced virulence |
ANNHBBDC_01639 | PHI:3040 | ClpP | 77.6 | 5.7e-85 | 9 | 200 | 0.9552 | 0.9275 | rodents | food poisoning | proteolytic component | reduced virulence |
ANNHBBDC_01659 | PHI:6438 | Ndk | 72.7 | 1.7e-54 | 1 | 143 | 1.0000 | 1.0000 | rodents | nosocomial infection | host-responsive regulator/nucleoside diphosphate kinase | increased virulence (hypervirulence) |
ANNHBBDC_01714 | PHI:11841 | barA | 100 | 0 | 1 | 935 | 1.0000 | 1.0000 | rodents | pneumonia | histidine kinase | unaffected pathogenicity |
ANNHBBDC_01718 | PHI:11295 | relA (ABUW_3302) | 100 | 0 | 1 | 768 | 1.0000 | 1.0000 | moths | nosocomial infection | GTP pyrophosphokinase | reduced virulence |
ANNHBBDC_01742 | PHI:123501 | lirL (ABUW_3278) | 77.5 | 1e-14 | 1 | 88 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipoprotein | reduced virulence |
ANNHBBDC_01744 | PHI:9285 | trxA | 100 | 2.1e-57 | 1 | 108 | 1.0000 | 1.0000 | rodents | pneumonia | thioredoxin A | reduced virulence |
ANNHBBDC_01759 | PHI:7669 | gigB | 100 | 1.3e-93 | 1 | 173 | 1.0000 | 0.9301 | moths | nosocomial infection | anti-sigma factor antagonist | reduced virulence |
ANNHBBDC_01760 | PHI:7668 | gigA | 100 | 1.5e-191 | 1 | 322 | 1.0000 | 1.0000 | moths | nosocomial infection | noncanonical two-component system (TCS) response regulator (RR) harboring a protein phosphatase domain | reduced virulence |
ANNHBBDC_01795 | PHI:10392 | pcoA (ABUW_3228) | 98 | 0 | 1 | 644 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein A | reduced virulence |
ANNHBBDC_01796 | PHI:10391 | pcoB (ABUW_3227) | 96.4 | 3.4e-143 | 1 | 251 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein B | reduced virulence |
ANNHBBDC_01852 | PHI:8937 | nuoI (PA2644) | 77.4 | 1.8e-82 | 4 | 180 | 0.9833 | 0.9615 | moths | nosocomial infection | NADH-quinone oxidoreductase | unaffected pathogenicity |
ANNHBBDC_01860 | PHI:124383 | GigC | 99.7 | 1.9e-169 | 1 | 295 | 1.0000 | 1.0000 | rodents | nosocomial infection | LysR family regulator | reduced virulence |
ANNHBBDC_01921 | PHI:6388 | adeK | 100 | 5.8e-269 | 1 | 484 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
ANNHBBDC_01922 | PHI:6387 | adeJ | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
ANNHBBDC_01923 | PHI:6386 | adeI | 100 | 2.5e-220 | 1 | 416 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
ANNHBBDC_01967 | PHI:7130 | greA | 70.9 | 6.7e-57 | 1 | 158 | 1.0000 | 1.0000 | rodents | salmonellosis | transcription elongation factor | loss of pathogenicity |
ANNHBBDC_01969 | PHI:6594 | carA | 72.1 | 1.8e-156 | 1 | 372 | 0.9815 | 0.9841 | eudicots | bacterial speck (tomato) | encodes the predicted small chain of carbamoylphosphate synthetase | reduced virulence |
ANNHBBDC_01994 | PHI:123702 | dgkA (PALES_47610) | 73.8 | 5.1e-44 | 3 | 124 | 0.9839 | 0.9919 | rodents | nosocomial infection | diacyl glycerol kinase | reduced virulence |
ANNHBBDC_02072 | PHI:123761 | pal | 83.5 | 1.4e-82 | 3 | 187 | 0.9893 | 0.9947 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
ANNHBBDC_02073 | PHI:123760 | tolB | 99.8 | 1.5e-244 | 1 | 426 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
ANNHBBDC_02076 | PHI:123757 | TolQ | 99.6 | 5.7e-121 | 1 | 232 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
ANNHBBDC_02187 | PHI:10561 | pstS | 100 | 2.4e-192 | 1 | 343 | 1.0000 | 1.0000 | primates | nosocomial infection | phosphate-binding protein | reduced virulence |
ANNHBBDC_02222 | PHI:3711 | PCC21 _023220 | 73.4 | 3.8e-84 | 8 | 206 | 0.9614 | 0.9614 | eudicots | soft rot | putative DNA-binding protein | reduced virulence |
ANNHBBDC_02233 | PHI:11832 | basD | 96.6 | 0 | 1 | 980 | 1.0000 | 1.0000 | rodents | pneumonia | acinetobactin non-ribosomal peptide synthetase subunit | reduced virulence |
ANNHBBDC_02236 | PHI:11830 | basG (A1S_2379) | 99.5 | 5e-231 | 1 | 383 | 1.0000 | 1.0000 | rodents | pneumonia | N-hydroxyhistamine synthesis | reduced virulence |
ANNHBBDC_02360 | PHI:6492 | lipA | 99.7 | 7.3e-202 | 1 | 337 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
ANNHBBDC_02465 | PHI:2962 | glyA | 70.7 | 3.8e-168 | 5 | 416 | 0.9880 | 0.9880 | bony fishes | enteric septicemia | serine hydroxymethyltransferase | reduced virulence |
ANNHBBDC_02496 | PHI:124230 | dctA | 72 | 7.6e-170 | 3 | 431 | 0.9491 | 0.9720 | rodents | salmonellosis | primary dicarboxylate importer | unaffected pathogenicity |
ANNHBBDC_02507 | PHI:123321 | thiG (pspto_0434) | 71.8 | 1.3e-102 | 3 | 257 | 0.9770 | 0.9659 | eudicots | bacterial speck | thiazole synthase | reduced virulence |
ANNHBBDC_02649 | PHI:6782 | kdpE | 97.1 | 2.4e-130 | 1 | 238 | 1.0000 | 1.0000 | rodents | pneumonia | potassium-dependent protein | reduced virulence |
ANNHBBDC_02773 | PHI:11023 | hfq | 85.1 | 9.1e-28 | 1 | 67 | 0.3988 | 0.7283 | moths | pleuropneumonia (pig) | RNA chaperone | reduced virulence |
ANNHBBDC_02894 | PHI:10611 | lpxD | 99.7 | 1.6e-202 | 1 | 356 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acylglucosamine N-acyltransferase | reduced virulence |
ANNHBBDC_02895 | PHI:10610 | lpxA | 100 | 7e-86 | 1 | 157 | 0.9752 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
ANNHBBDC_02896 | PHI:10610 | lpxA | 99.6 | 6.6e-150 | 1 | 262 | 1.0000 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
ANNHBBDC_02899 | PHI:10380 | RecA | 100 | 2e-194 | 1 | 349 | 1.0000 | 1.0000 | nematodes | nosocomial infection | DNA strand exchange and recombination protein | reduced virulence |
ANNHBBDC_02964 | PHI:11208 | clpS | 100 | 2.3e-77 | 1 | 137 | 1.0000 | 1.0000 | rodents | nosocomial infection | ATP-dependent Clp protease adapter protein | reduced virulence |
ANNHBBDC_03094 | PHI:5092 | PLD1 | 98.7 | 3.8e-84 | 1 | 152 | 0.9560 | 0.9921 | moths | nosocomial infection | phospholipases D | reduced virulence |
ANNHBBDC_03095 | PHI:5092 | PLD1 | 98 | 7.6e-202 | 1 | 352 | 1.0000 | 0.9921 | moths | nosocomial infection | phospholipases D | reduced virulence |
ANNHBBDC_03223 | PHI:6492 | lipA | 75.2 | 2.9e-147 | 1 | 319 | 0.9726 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
ANNHBBDC_03244 | PHI:123759 | tolA | 99.2 | 1e-63 | 1 | 124 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
ANNHBBDC_03301 | PHI:6892 | iscU | 83.2 | 3.8e-58 | 1 | 125 | 0.9766 | 0.9766 | rodents | salmonellosis | Fe-S cluster sensor | reduced virulence |
ANNHBBDC_03365 | PHI:11868 | otsA | 99.5 | 0 | 1 | 813 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein A | reduced virulence |
ANNHBBDC_03538 | PHI:6090 | katE | 99.7 | 0 | 1 | 712 | 1.0000 | 1.0000 | moths | bacteremia | hydroperoxidase | increased virulence (hypervirulence) |
ANNHBBDC_03664 | PHI:5090 | tssM | 97.1 | 0 | 28 | 1274 | 0.9788 | 1.0000 | moths | nosocomial infection | T6SS effector | effector (plant avirulence determinant) |
ANNHBBDC_03825 | PHI:8812 | CopA (ABUW_2707) | 98.2 | 0 | 1 | 823 | 1.0000 | 1.0000 | rodents | nosocomial infection | copper-translocating P-type ATPase | unaffected pathogenicity |
ANNHBBDC_03845 | PHI:11383 | ahpC | 71.7 | 5.5e-82 | 1 | 187 | 1.0000 | 1.0000 | moths | salmonellosis | peroxiredoxin | reduced virulence |
ANNHBBDC_03853 | PHI:124297 | TrmB (OB946_12575) | 99.2 | 1.9e-140 | 1 | 238 | 1.0000 | 0.9675 | rodents | nosocomial infection | tRNA methyltransferase | reduced virulence |
ANNHBBDC_03863 | PHI:11207 | clpB | 100 | 0 | 1 | 859 | 1.0000 | 1.0000 | rodents | nosocomial infection | protein disaggregation chaperone | reduced virulence |
ANNHBBDC_03946 | PHI:11447 | csrA | 100 | 6.1e-41 | 1 | 84 | 1.0000 | 1.0000 | moths | nosocomial infection | carbon storage regulator | reduced virulence |
BIMJNAPA_00060 | PHI:9898 | ata | 76.9 | 0 | 1 | 1820 | 0.8930 | 0.9616 | primates | nosocomial infection | trimeric autotransporter adhesin | reduced virulence |
BIMJNAPA_00166 | PHI:7520 | VK055_1952 | 75.4 | 6e-213 | 8 | 490 | 0.9857 | 0.9918 | rodents | pneumonia | betaine aldehyde dehydrogenase | unaffected pathogenicity |
BIMJNAPA_00202 | PHI:10510 | ggt | 99.1 | 0 | 1 | 661 | 1.0000 | 1.0000 | rodents | nosocomial infection | gamma-glutamyltransferase | reduced virulence |
BIMJNAPA_00245 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
BIMJNAPA_00388 | PHI:11869 | otsB | 96.8 | 2.9e-159 | 1 | 283 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein B | unaffected pathogenicity |
BIMJNAPA_00392 | PHI:7809 | adeN | 99.9 | 0 | 1 | 678 | 1.0000 | 1.0000 | moths | nosocomial infection | TetR type regulator | increased virulence (hypervirulence) |
BIMJNAPA_00474 | PHI:10421 | PilG (XC_1183) | 75.8 | 2.9e-50 | 8 | 127 | 0.9449 | 0.9023 | eudicots | black rot | single domain response regulator | reduced virulence |
BIMJNAPA_00494 | PHI:11030 | bipA | 70.9 | 2.1e-247 | 4 | 607 | 0.9885 | 0.9852 | rodents | pneumonic plague | putative GTPase | reduced virulence |
BIMJNAPA_00500 | PHI:9283 | OmpA | 99.4 | 8.5e-201 | 1 | 356 | 1.0000 | 1.0000 | nematodes | pneumonia | outer membrane protein | reduced virulence |
BIMJNAPA_00520 | PHI:5240 | secA | 99.8 | 0 | 1 | 907 | 1.0000 | 1.0000 | moths | nosocomial infection | iron utilization | reduced virulence |
BIMJNAPA_00521 | PHI:3243 | lsfA | 79.7 | 2.3e-100 | 1 | 212 | 0.9953 | 1.0000 | rodents | opportunistic infection | 1-Cys peroxiredoxin with thioldependent peroxidase activity | reduced virulence |
BIMJNAPA_00548 | PHI:5094 | PLD3 | 98.6 | 9.3e-283 | 1 | 487 | 1.0000 | 1.0000 | moths | nosocomial infection | phospholipases D | reduced virulence |
BIMJNAPA_00607 | PHI:5093 | PLD2 | 99.8 | 5.10000000016164e-314 | 1 | 541 | 1.0000 | 0.9963 | moths | nosocomial infection | phospholipases D | reduced virulence |
BIMJNAPA_00614 | PHI:10160 | ksgA | 100 | 2e-154 | 1 | 270 | 1.0000 | 1.0000 | nematodes | skin infection; soft tissue infection; urinary tract infection; meningitis; wound infection | 16S rRNA methyltransferase | reduced virulence |
BIMJNAPA_00694 | PHI:11120 | rplN | 74.6 | 3.2e-46 | 1 | 122 | 1.0000 | 1.0000 | primates | pertussis | 50S ribosomal protein | unaffected pathogenicity |
BIMJNAPA_00875 | PHI:10701 | hisF (A1S_3245) | 100 | 1.5e-143 | 1 | 252 | 1.0000 | 1.0000 | rodents | pneumonia | imidazole glycerol phosphate synthase cyclase subunit | reduced virulence |
BIMJNAPA_00972 | PHI:10612 | lpxC | 100 | 1.6e-171 | 1 | 300 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acyl-N-acetylglucosamine deacetylase | reduced virulence |
BIMJNAPA_01036 | PHI:8042 | lpxA | 99.8 | 9.7e-258 | 1 | 454 | 1.0000 | 1.0000 | rodents | pneumonia | N-acetylglucosamine-1-phosphate uridyltransferase | reduced virulence |
BIMJNAPA_01068 | PHI:123477 | Oxa-2 | 100 | 5.1e-161 | 1 | 275 | 1.0000 | 1.0000 | moths | nosocomial infection | beta-lactamase | reduced virulence |
BIMJNAPA_01209 | PHI:124392 | wzc | 95.6 | 0 | 1 | 728 | 1.0000 | 1.0000 | moths | nosocomial infection | multidrug-resistant factor | unaffected pathogenicity |
BIMJNAPA_01269 | PHI:8774 | abaI | 95.7 | 1.3e-99 | 1 | 183 | 1.0000 | 1.0000 | moths | nosocomial infection | acyl-homoserine-lactone synthase | reduced virulence |
BIMJNAPA_01270 | PHI:11261 | abaM (ABUW_3775) | 99.3 | 2.5e-76 | 1 | 138 | 1.0000 | 1.0000 | moths | nosocomial infection | DUF4902 domain-containing protein | reduced virulence |
BIMJNAPA_01329 | PHI:9117 | TonB-dependent copper receptor | 99.1 | 0 | 1 | 704 | 1.0000 | 1.0000 | rodents | nosocomial infection | TonB-dependent copper receptor, outer membraneprotein | reduced virulence |
BIMJNAPA_01361 | PHI:11092 | oprD | 99.5 | 9.7e-255 | 1 | 438 | 1.0000 | 1.0000 | rodents | pneumonia | outer membrane protein | reduced virulence |
BIMJNAPA_01397 | PHI:6601 | gacA | 100 | 8e-114 | 1 | 211 | 1.0000 | 1.0000 | bony fishes | bacteremia | response regulator | reduced virulence |
BIMJNAPA_01409 | PHI:11772 | dksA (AlS_0248 ) | 100 | 4.4e-97 | 1 | 178 | 1.0000 | 1.0000 | rodents | nosocomial infection | RNA polymerase-binding transcription factor | reduced virulence |
BIMJNAPA_01416 | PHI:4996 | AbuO | 99.3 | 2.4e-245 | 1 | 448 | 1.0000 | 1.0000 | nematodes | nosocomial infection | outer membrane protein | reduced virulence |
BIMJNAPA_01431 | PHI:123173 | gspD | 90.3 | 0 | 1 | 756 | 1.0000 | 1.0000 | rodents | urinary tract infection | type II secretion (T2S) system that is responsible for secretion of InvL | reduced virulence |
BIMJNAPA_01439 | PHI:10282 | tufA | 74.6 | 3e-170 | 1 | 394 | 0.9949 | 0.9949 | primates | skin infection; food poisoning; respiratory disease | elongation factor Tu | increased virulence (hypervirulence) |
BIMJNAPA_01447 | PHI:7860 | RpoB | 99.8 | 0 | 1 | 1357 | 0.9963 | 1.0000 | nematodes | nosocomial infection | beta-subunit of the RNA polymerase | reduced virulence |
BIMJNAPA_01570 | PHI:6089 | katG | 96.1 | 0 | 1 | 718 | 1.0000 | 1.0000 | moths | bacteremia | catalase-peroxidase | increased virulence (hypervirulence) |
BIMJNAPA_01578 | PHI:9981 | leuC (PXO_02613) | 74.5 | 2.5e-209 | 38 | 507 | 0.9234 | 0.9751 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase large subunit | reduced virulence |
BIMJNAPA_01579 | PHI:9980 | leuD (PXO_02612) | 72.5 | 1.5e-91 | 1 | 211 | 0.9814 | 0.9814 | monocots | bacterial leaf blight | 3-isopropylmalate dehydratase small subunit | reduced virulence |
BIMJNAPA_01581 | PHI:9979 | leuB (PXO_02610) | 72.9 | 1.1e-144 | 1 | 358 | 0.9972 | 1.0000 | monocots | bacterial leaf blight | 3-isopropylmalate dehydrogenase | reduced virulence |
BIMJNAPA_01592 | PHI:124242 | gltP | 73.1 | 2.7e-169 | 1 | 424 | 0.9907 | 0.9703 | rodents | neonatal meningitis | glutamate transporters | reduced virulence |
BIMJNAPA_01639 | PHI:3040 | ClpP | 77.6 | 5.7e-85 | 9 | 200 | 0.9552 | 0.9275 | rodents | food poisoning | proteolytic component | reduced virulence |
BIMJNAPA_01659 | PHI:6438 | Ndk | 72.7 | 1.7e-54 | 1 | 143 | 1.0000 | 1.0000 | rodents | nosocomial infection | host-responsive regulator/nucleoside diphosphate kinase | increased virulence (hypervirulence) |
BIMJNAPA_01714 | PHI:11841 | barA | 100 | 0 | 1 | 935 | 1.0000 | 1.0000 | rodents | pneumonia | histidine kinase | unaffected pathogenicity |
BIMJNAPA_01718 | PHI:11295 | relA (ABUW_3302) | 100 | 0 | 1 | 768 | 1.0000 | 1.0000 | moths | nosocomial infection | GTP pyrophosphokinase | reduced virulence |
BIMJNAPA_01742 | PHI:123501 | lirL (ABUW_3278) | 77.5 | 1e-14 | 1 | 88 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipoprotein | reduced virulence |
BIMJNAPA_01744 | PHI:9285 | trxA | 100 | 2.1e-57 | 1 | 108 | 1.0000 | 1.0000 | rodents | pneumonia | thioredoxin A | reduced virulence |
BIMJNAPA_01759 | PHI:7669 | gigB | 100 | 1.3e-93 | 1 | 173 | 1.0000 | 0.9301 | moths | nosocomial infection | anti-sigma factor antagonist | reduced virulence |
BIMJNAPA_01760 | PHI:7668 | gigA | 100 | 1.5e-191 | 1 | 322 | 1.0000 | 1.0000 | moths | nosocomial infection | noncanonical two-component system (TCS) response regulator (RR) harboring a protein phosphatase domain | reduced virulence |
BIMJNAPA_01795 | PHI:10392 | pcoA (ABUW_3228) | 98 | 0 | 1 | 644 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein A | reduced virulence |
BIMJNAPA_01796 | PHI:10391 | pcoB (ABUW_3227) | 96.4 | 3.4e-143 | 1 | 251 | 1.0000 | 1.0000 | moths | nosocomial infection | copper resistance protein B | reduced virulence |
BIMJNAPA_01852 | PHI:8937 | nuoI (PA2644) | 77.4 | 1.8e-82 | 4 | 180 | 0.9833 | 0.9615 | moths | nosocomial infection | NADH-quinone oxidoreductase | unaffected pathogenicity |
BIMJNAPA_01860 | PHI:124383 | GigC | 99.7 | 1.9e-169 | 1 | 295 | 1.0000 | 1.0000 | rodents | nosocomial infection | LysR family regulator | reduced virulence |
BIMJNAPA_01921 | PHI:6388 | adeK | 100 | 5.8e-269 | 1 | 484 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
BIMJNAPA_01922 | PHI:6387 | adeJ | 99.9 | 0 | 1 | 1058 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
BIMJNAPA_01923 | PHI:6386 | adeI | 100 | 2.5e-220 | 1 | 416 | 1.0000 | 1.0000 | rodents | pneumonia; bloodstream infection | multidrug efflux protein | unaffected pathogenicity |
BIMJNAPA_01967 | PHI:7130 | greA | 70.9 | 6.7e-57 | 1 | 158 | 1.0000 | 1.0000 | rodents | salmonellosis | transcription elongation factor | loss of pathogenicity |
BIMJNAPA_01969 | PHI:6594 | carA | 72.1 | 1.8e-156 | 1 | 372 | 0.9815 | 0.9841 | eudicots | bacterial speck (tomato) | encodes the predicted small chain of carbamoylphosphate synthetase | reduced virulence |
BIMJNAPA_01994 | PHI:123702 | dgkA (PALES_47610) | 73.8 | 5.1e-44 | 3 | 124 | 0.9839 | 0.9919 | rodents | nosocomial infection | diacyl glycerol kinase | reduced virulence |
BIMJNAPA_02072 | PHI:123761 | pal | 83.5 | 1.4e-82 | 3 | 187 | 0.9893 | 0.9947 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
BIMJNAPA_02073 | PHI:123760 | tolB | 99.8 | 1.5e-244 | 1 | 426 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
BIMJNAPA_02076 | PHI:123757 | TolQ | 99.6 | 5.7e-121 | 1 | 232 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
BIMJNAPA_02187 | PHI:10561 | pstS | 100 | 2.4e-192 | 1 | 343 | 1.0000 | 1.0000 | primates | nosocomial infection | phosphate-binding protein | reduced virulence |
BIMJNAPA_02222 | PHI:3711 | PCC21 _023220 | 73.4 | 3.8e-84 | 8 | 206 | 0.9614 | 0.9614 | eudicots | soft rot | putative DNA-binding protein | reduced virulence |
BIMJNAPA_02233 | PHI:11832 | basD | 96.6 | 0 | 1 | 980 | 1.0000 | 1.0000 | rodents | pneumonia | acinetobactin non-ribosomal peptide synthetase subunit | reduced virulence |
BIMJNAPA_02236 | PHI:11830 | basG (A1S_2379) | 99.5 | 5e-231 | 1 | 383 | 1.0000 | 1.0000 | rodents | pneumonia | N-hydroxyhistamine synthesis | reduced virulence |
BIMJNAPA_02360 | PHI:6492 | lipA | 99.7 | 7.3e-202 | 1 | 337 | 1.0000 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
BIMJNAPA_02465 | PHI:2962 | glyA | 70.7 | 3.8e-168 | 5 | 416 | 0.9880 | 0.9880 | bony fishes | enteric septicemia | serine hydroxymethyltransferase | reduced virulence |
BIMJNAPA_02496 | PHI:124230 | dctA | 72 | 7.6e-170 | 3 | 431 | 0.9491 | 0.9720 | rodents | salmonellosis | primary dicarboxylate importer | unaffected pathogenicity |
BIMJNAPA_02507 | PHI:123321 | thiG (pspto_0434) | 71.8 | 1.3e-102 | 3 | 257 | 0.9770 | 0.9659 | eudicots | bacterial speck | thiazole synthase | reduced virulence |
BIMJNAPA_02649 | PHI:6782 | kdpE | 97.1 | 2.4e-130 | 1 | 238 | 1.0000 | 1.0000 | rodents | pneumonia | potassium-dependent protein | reduced virulence |
BIMJNAPA_02773 | PHI:11023 | hfq | 85.1 | 9.1e-28 | 1 | 67 | 0.3988 | 0.7283 | moths | pleuropneumonia (pig) | RNA chaperone | reduced virulence |
BIMJNAPA_02894 | PHI:10611 | lpxD | 99.7 | 1.6e-202 | 1 | 356 | 1.0000 | 1.0000 | primates | nosocomial infection | UDP-3-O-acylglucosamine N-acyltransferase | reduced virulence |
BIMJNAPA_02895 | PHI:10610 | lpxA | 100 | 7e-86 | 1 | 157 | 0.9752 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
BIMJNAPA_02896 | PHI:10610 | lpxA | 99.6 | 6.6e-150 | 1 | 262 | 1.0000 | 0.9905 | primates | nosocomial infection | multifunctional fusion protein | reduced virulence |
BIMJNAPA_02899 | PHI:10380 | RecA | 100 | 2e-194 | 1 | 349 | 1.0000 | 1.0000 | nematodes | nosocomial infection | DNA strand exchange and recombination protein | reduced virulence |
BIMJNAPA_02964 | PHI:11208 | clpS | 100 | 2.3e-77 | 1 | 137 | 1.0000 | 1.0000 | rodents | nosocomial infection | ATP-dependent Clp protease adapter protein | reduced virulence |
BIMJNAPA_03094 | PHI:5092 | PLD1 | 98.7 | 3.8e-84 | 1 | 152 | 0.9560 | 0.9921 | moths | nosocomial infection | phospholipases D | reduced virulence |
BIMJNAPA_03095 | PHI:5092 | PLD1 | 98 | 7.6e-202 | 1 | 352 | 1.0000 | 0.9921 | moths | nosocomial infection | phospholipases D | reduced virulence |
BIMJNAPA_03223 | PHI:6492 | lipA | 75.2 | 2.9e-147 | 1 | 319 | 0.9726 | 1.0000 | rodents | nosocomial infection | lipase | reduced virulence |
BIMJNAPA_03244 | PHI:123759 | tolA | 99.2 | 1e-63 | 1 | 124 | 1.0000 | 1.0000 | moths | nosocomial infection | Tol-Pal system protein | reduced virulence |
BIMJNAPA_03301 | PHI:6892 | iscU | 83.2 | 3.8e-58 | 1 | 125 | 0.9766 | 0.9766 | rodents | salmonellosis | Fe-S cluster sensor | reduced virulence |
BIMJNAPA_03365 | PHI:11868 | otsA | 99.5 | 0 | 1 | 813 | 1.0000 | 1.0000 | primates | nosocomial infection | osmoregulatory trehalose synthesis protein A | reduced virulence |
BIMJNAPA_03538 | PHI:6090 | katE | 99.7 | 0 | 1 | 712 | 1.0000 | 1.0000 | moths | bacteremia | hydroperoxidase | increased virulence (hypervirulence) |
BIMJNAPA_03664 | PHI:5090 | tssM | 97.1 | 0 | 28 | 1274 | 0.9788 | 1.0000 | moths | nosocomial infection | T6SS effector | effector (plant avirulence determinant) |
BIMJNAPA_03825 | PHI:8812 | CopA (ABUW_2707) | 98.2 | 0 | 1 | 823 | 1.0000 | 1.0000 | rodents | nosocomial infection | copper-translocating P-type ATPase | unaffected pathogenicity |
BIMJNAPA_03845 | PHI:11383 | ahpC | 71.7 | 5.5e-82 | 1 | 187 | 1.0000 | 1.0000 | moths | salmonellosis | peroxiredoxin | reduced virulence |
BIMJNAPA_03853 | PHI:124297 | TrmB (OB946_12575) | 99.2 | 1.9e-140 | 1 | 238 | 1.0000 | 0.9675 | rodents | nosocomial infection | tRNA methyltransferase | reduced virulence |
BIMJNAPA_03863 | PHI:11207 | clpB | 100 | 0 | 1 | 859 | 1.0000 | 1.0000 | rodents | nosocomial infection | protein disaggregation chaperone | reduced virulence |
BIMJNAPA_03946 | PHI:11447 | csrA | 100 | 6.1e-41 | 1 | 84 | 1.0000 | 1.0000 | moths | nosocomial infection | carbon storage regulator | reduced virulence |
Gene Name | cazy_id | identity | evalue | qstart | qend | query_coverage | subject_coverage |
---|---|---|---|---|---|---|---|
ANNHBBDC_00105 | AVE54575.1|GT51 | 100 | 2.83e-162 | 1 | 225 | 1 | 1 |
ANNHBBDC_00154 | ANC38059.1|GT2 | 100 | 1.68000000001837e-313 | 1 | 419 | 1 | 1 |
ANNHBBDC_00155 | ANC38058.1|CE4|GH153 | 100 | 0 | 1 | 664 | 1 | 1 |
ANNHBBDC_00273 | QFY68328.1|GH108 | 99.4 | 5.92e-131 | 1 | 181 | 1 | 1 |
ANNHBBDC_00285 | QIT17608.1|GH23 | 78.4 | 0 | 1 | 1435 | 1 | 0.9993 |
ANNHBBDC_00372 | ARG29438.1|CBM50 | 100 | 1.7e-107 | 1 | 157 | 1 | 1 |
ANNHBBDC_00389 | ANC37923.1|GT20 | 100 | 0 | 1 | 476 | 1 | 1 |
ANNHBBDC_00558 | ANC36675.1|GT25 | 100 | 2.18e-132 | 1 | 188 | 1 | 0.7287 |
ANNHBBDC_00559 | AIL79204.1|GT25 | 100 | 7.48e-182 | 1 | 255 | 1 | 1 |
ANNHBBDC_00561 | AIL79206.1|GT4 | 100 | 1.8e-245 | 1 | 344 | 1 | 1 |
ANNHBBDC_00562 | AXX42478.1|GT2 | 100 | 4.7e-185 | 1 | 255 | 1 | 1 |
ANNHBBDC_00644 | AHB90183.1|GH23 | 100 | 0 | 1 | 661 | 1 | 1 |
ANNHBBDC_00653 | CAD7285530.1|AA6 | 87.3 | 3.19e-104 | 19 | 184 | 0.8426 | 1 |
ANNHBBDC_00825 | QBY15825.1|GT51 | 100 | 0 | 1 | 851 | 1 | 1 |
ANNHBBDC_00953 | APJ17755.1|GT30 | 100 | 0 | 1 | 430 | 1 | 1 |
ANNHBBDC_00972 | APO57399.1|CE11 | 100 | 1.04e-215 | 1 | 300 | 1 | 1 |
ANNHBBDC_00977 | QJH11984.1|GT28 | 100 | 3.24e-251 | 1 | 364 | 0.4272 | 0.9973 |
ANNHBBDC_00994 | APJ17715.1|CE4 | 100 | 1.32e-249 | 1 | 321 | 1 | 1 |
ANNHBBDC_01159 | ANB90480.1|GH103 | 100 | 1.44999999853954e-315 | 1 | 430 | 1 | 1 |
ANNHBBDC_01216 | SBS23909.1|GT0 | 100 | 1.91e-258 | 1 | 348 | 1 | 1 |
ANNHBBDC_01223 | ATU21389.1|GT0 | 100 | 3.61e-203 | 1 | 274 | 1 | 1 |
ANNHBBDC_01224 | AWW83171.1|GT2 | 100 | 2.64e-202 | 1 | 277 | 1 | 1 |
ANNHBBDC_01326 | QJG70538.1|CBM50 | 100 | 8.88e-289 | 1 | 384 | 1 | 1 |
ANNHBBDC_01340 | AOX71963.1|GH23 | 100 | 5.86e-115 | 1 | 162 | 1 | 1 |
ANNHBBDC_01349 | AOX87537.1|GH25 | 100 | 6.23e-193 | 1 | 252 | 1 | 1 |
ANNHBBDC_01593 | AVE54043.1|GT4 | 100 | 4.77e-268 | 1 | 366 | 1 | 1 |
ANNHBBDC_01654 | ANC37654.1|GH3 | 100 | 9.61e-243 | 1 | 339 | 1 | 1 |
ANNHBBDC_01656 | AIL80263.1|GT4 | 100 | 3.11999999842487e-316 | 1 | 428 | 1 | 1 |
ANNHBBDC_01950 | WGE29869.1|GT51 | 73 | 9.7e-121 | 8 | 232 | 0.9534 | 0.9664 |
ANNHBBDC_02000 | AVI37114.1|GH23 | 100 | 6.92e-184 | 1 | 258 | 1 | 1 |
ANNHBBDC_02003 | AOX98022.1|GH23 | 100 | 2.66e-267 | 1 | 370 | 1 | 1 |
ANNHBBDC_02041 | AXX41186.1|GT83 | 100 | 0 | 1 | 548 | 1 | 1 |
ANNHBBDC_02043 | QJG79341.1|GT2 | 100 | 2.42e-234 | 1 | 326 | 1 | 1 |
ANNHBBDC_02147 | QFY68041.1|GT2 | 100 | 1.56e-309 | 1 | 416 | 0.9858 | 1 |
ANNHBBDC_02204 | ANA38132.1|CBM50 | 100 | 1.13e-182 | 1 | 276 | 1 | 1 |
ANNHBBDC_02324 | ATP86570.1|GH23 | 84.7 | 0 | 1 | 1631 | 1 | 1 |
ANNHBBDC_02332 | ASO70632.1|GH108 | 100 | 4.88e-134 | 1 | 180 | 1 | 1 |
ANNHBBDC_02375 | ATU48435.1|GH103 | 100 | 1.32e-246 | 1 | 333 | 1 | 1 |
ANNHBBDC_02445 | QIT17608.1|GH23 | 78.4 | 0 | 1 | 1435 | 1 | 0.9993 |
ANNHBBDC_02457 | QFY68328.1|GH108 | 99.4 | 5.92e-131 | 1 | 181 | 1 | 1 |
ANNHBBDC_02492 | AEK25780.1|GT51 | 100 | 0 | 1 | 798 | 1 | 1 |
ANNHBBDC_02522 | AKG15280.2|GH103 | 70.2 | 1.08e-258 | 1 | 510 | 0.9942 | 0.9941 |
ANNHBBDC_02555 | ATI39166.1|GT2 | 100 | 3.21e-158 | 1 | 214 | 1 | 1 |
ANNHBBDC_02624 | AXG85579.1|CE4 | 100 | 0 | 1 | 609 | 1 | 1 |
ANNHBBDC_02625 | QCP29254.1|GT2 | 100 | 9.68000000000016e-311 | 1 | 415 | 1 | 1 |
ANNHBBDC_03261 | ANC35291.1|GT19 | 100 | 2.15e-279 | 1 | 391 | 1 | 1 |
ANNHBBDC_03748 | AYY16682.1|GH24 | 99.5 | 5.02e-146 | 1 | 202 | 0.8145 | 0.9854 |
ANNHBBDC_03756 | AXX40801.1|GH23 | 100 | 0 | 1 | 749 | 1 | 1 |
ANNHBBDC_03812 | AXX40855.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
ANNHBBDC_03881 | ATD20568.1|GH108 | 100 | 1.7e-130 | 1 | 181 | 1 | 1 |
ANNHBBDC_03995 | AXX43016.1|CBM50|GH23 | 100 | 0 | 1 | 1020 | 0.9524 | 0.9524 |
ANNHBBDC_04023 | AXX42993.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
ANNHBBDC_04030 | QFY69710.1|GH23 | 100 | 0 | 1 | 1580 | 1 | 1 |
BIMJNAPA_00105 | AVE54575.1|GT51 | 100 | 2.83e-162 | 1 | 225 | 1 | 1 |
BIMJNAPA_00154 | ANC38059.1|GT2 | 100 | 1.68000000001837e-313 | 1 | 419 | 1 | 1 |
BIMJNAPA_00155 | ANC38058.1|CE4|GH153 | 100 | 0 | 1 | 664 | 1 | 1 |
BIMJNAPA_00273 | QFY68328.1|GH108 | 99.4 | 5.92e-131 | 1 | 181 | 1 | 1 |
BIMJNAPA_00285 | QIT17608.1|GH23 | 78.4 | 0 | 1 | 1435 | 1 | 0.9993 |
BIMJNAPA_00372 | ARG29438.1|CBM50 | 100 | 1.7e-107 | 1 | 157 | 1 | 1 |
BIMJNAPA_00389 | ANC37923.1|GT20 | 100 | 0 | 1 | 476 | 1 | 1 |
BIMJNAPA_00558 | ANC36675.1|GT25 | 100 | 2.18e-132 | 1 | 188 | 1 | 0.7287 |
BIMJNAPA_00559 | AIL79204.1|GT25 | 100 | 7.48e-182 | 1 | 255 | 1 | 1 |
BIMJNAPA_00561 | AIL79206.1|GT4 | 100 | 1.8e-245 | 1 | 344 | 1 | 1 |
BIMJNAPA_00562 | AXX42478.1|GT2 | 100 | 4.7e-185 | 1 | 255 | 1 | 1 |
BIMJNAPA_00644 | AHB90183.1|GH23 | 100 | 0 | 1 | 661 | 1 | 1 |
BIMJNAPA_00653 | CAD7285530.1|AA6 | 87.3 | 3.19e-104 | 19 | 184 | 0.8426 | 1 |
BIMJNAPA_00825 | QBY15825.1|GT51 | 100 | 0 | 1 | 851 | 1 | 1 |
BIMJNAPA_00953 | APJ17755.1|GT30 | 100 | 0 | 1 | 430 | 1 | 1 |
BIMJNAPA_00972 | APO57399.1|CE11 | 100 | 1.04e-215 | 1 | 300 | 1 | 1 |
BIMJNAPA_00977 | QJH11984.1|GT28 | 100 | 3.24e-251 | 1 | 364 | 0.4272 | 0.9973 |
BIMJNAPA_00994 | APJ17715.1|CE4 | 100 | 1.32e-249 | 1 | 321 | 1 | 1 |
BIMJNAPA_01159 | ANB90480.1|GH103 | 100 | 1.44999999853954e-315 | 1 | 430 | 1 | 1 |
BIMJNAPA_01216 | SBS23909.1|GT0 | 100 | 1.91e-258 | 1 | 348 | 1 | 1 |
BIMJNAPA_01223 | ATU21389.1|GT0 | 100 | 3.61e-203 | 1 | 274 | 1 | 1 |
BIMJNAPA_01224 | AWW83171.1|GT2 | 100 | 2.64e-202 | 1 | 277 | 1 | 1 |
BIMJNAPA_01326 | QJG70538.1|CBM50 | 100 | 8.88e-289 | 1 | 384 | 1 | 1 |
BIMJNAPA_01340 | AOX71963.1|GH23 | 100 | 5.86e-115 | 1 | 162 | 1 | 1 |
BIMJNAPA_01349 | AOX87537.1|GH25 | 100 | 6.23e-193 | 1 | 252 | 1 | 1 |
BIMJNAPA_01593 | AVE54043.1|GT4 | 100 | 4.77e-268 | 1 | 366 | 1 | 1 |
BIMJNAPA_01654 | ANC37654.1|GH3 | 100 | 9.61e-243 | 1 | 339 | 1 | 1 |
BIMJNAPA_01656 | AIL80263.1|GT4 | 100 | 3.11999999842487e-316 | 1 | 428 | 1 | 1 |
BIMJNAPA_01950 | WGE29869.1|GT51 | 73 | 9.7e-121 | 8 | 232 | 0.9534 | 0.9664 |
BIMJNAPA_02000 | AVI37114.1|GH23 | 100 | 6.92e-184 | 1 | 258 | 1 | 1 |
BIMJNAPA_02003 | AOX98022.1|GH23 | 100 | 2.66e-267 | 1 | 370 | 1 | 1 |
BIMJNAPA_02041 | AXX41186.1|GT83 | 100 | 0 | 1 | 548 | 1 | 1 |
BIMJNAPA_02043 | QJG79341.1|GT2 | 100 | 2.42e-234 | 1 | 326 | 1 | 1 |
BIMJNAPA_02147 | QFY68041.1|GT2 | 100 | 1.56e-309 | 1 | 416 | 0.9858 | 1 |
BIMJNAPA_02204 | ANA38132.1|CBM50 | 100 | 1.13e-182 | 1 | 276 | 1 | 1 |
BIMJNAPA_02324 | ATP86570.1|GH23 | 84.7 | 0 | 1 | 1631 | 1 | 1 |
BIMJNAPA_02332 | ASO70632.1|GH108 | 100 | 4.88e-134 | 1 | 180 | 1 | 1 |
BIMJNAPA_02375 | ATU48435.1|GH103 | 100 | 1.32e-246 | 1 | 333 | 1 | 1 |
BIMJNAPA_02445 | QIT17608.1|GH23 | 78.4 | 0 | 1 | 1435 | 1 | 0.9993 |
BIMJNAPA_02457 | QFY68328.1|GH108 | 99.4 | 5.92e-131 | 1 | 181 | 1 | 1 |
BIMJNAPA_02492 | AEK25780.1|GT51 | 100 | 0 | 1 | 798 | 1 | 1 |
BIMJNAPA_02522 | AKG15280.2|GH103 | 70.2 | 1.08e-258 | 1 | 510 | 0.9942 | 0.9941 |
BIMJNAPA_02555 | ATI39166.1|GT2 | 100 | 3.21e-158 | 1 | 214 | 1 | 1 |
BIMJNAPA_02624 | AXG85579.1|CE4 | 100 | 0 | 1 | 609 | 1 | 1 |
BIMJNAPA_02625 | QCP29254.1|GT2 | 100 | 9.68000000000016e-311 | 1 | 415 | 1 | 1 |
BIMJNAPA_03261 | ANC35291.1|GT19 | 100 | 2.15e-279 | 1 | 391 | 1 | 1 |
BIMJNAPA_03748 | AYY16682.1|GH24 | 99.5 | 5.02e-146 | 1 | 202 | 0.8145 | 0.9854 |
BIMJNAPA_03756 | AXX40801.1|GH23 | 100 | 0 | 1 | 749 | 1 | 1 |
BIMJNAPA_03812 | AXX40855.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
BIMJNAPA_03881 | ATD20568.1|GH108 | 100 | 1.7e-130 | 1 | 181 | 1 | 1 |
BIMJNAPA_03995 | AXX43016.1|CBM50|GH23 | 100 | 0 | 1 | 1020 | 0.9524 | 0.9524 |
BIMJNAPA_04023 | AXX42993.1|GH108 | 100 | 6.16e-133 | 1 | 181 | 1 | 1 |
BIMJNAPA_04030 | QFY69710.1|GH23 | 100 | 0 | 1 | 1580 | 1 | 1 |
Gene Name | tcid | identity | evalue | qstart | qend | query_coverage | subject_coverage | class_field | class_term | subclass | subclass_term | family | family_term |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANNHBBDC_00060 | 1.B.40.2.6 | 76.9 | 0 | 1 | 1820 | 0.8930 | 0.9616 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.40 | The Autotransporter-2 (AT-2) Family |
ANNHBBDC_00174 | 9.B.143.1.2 | 76.3 | 9e-90 | 1 | 232 | 0.9872 | 0.9788 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.143 | The 6 TMS DUF1275/Pf06912 (DUF1275) Family |
ANNHBBDC_00187 | 1.B.25.3.1 | 96.9 | 7.3e-266 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
ANNHBBDC_00203 | 2.A.1.3.62 | 99.8 | 1.1e-286 | 1 | 507 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
ANNHBBDC_00216 | 3.A.15.2.1 | 84 | 9.9e-165 | 11 | 354 | 0.9690 | 2.4397 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.15 | The Outer Membrane Protein Secreting Main Terminal Branch (MTB) Family |
ANNHBBDC_00368 | 9.B.8.2.5 | 96.2 | 8.8e-267 | 1 | 506 | 0.8533 | 0.9806 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.8 | The DUF2157 (DUF2157) Family |
ANNHBBDC_00477 | 2.A.6.3.3 | 99.8 | 0 | 22 | 1032 | 0.9797 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_00500 | 1.B.6.1.24 | 99.4 | 1.9e-200 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
ANNHBBDC_00605 | 1.B.6.1.26 | 100 | 7.5e-88 | 1 | 159 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
ANNHBBDC_00775 | 2.A.1.2.51 | 99.2 | 3.3e-192 | 1 | 362 | 0.9972 | 0.8765 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
ANNHBBDC_00939 | 1.A.1.28.6 | 99.6 | 2.3e-122 | 1 | 230 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.1 | The Voltage-gated Ion Channel (VIC) Superfamily |
ANNHBBDC_00958 | 1.B.1.2.1 | 99.6 | 1.6e-145 | 1 | 255 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.1 | The General Bacterial Porin (GBP) Family |
ANNHBBDC_01044 | 2.A.3.1.9 | 71.2 | 5e-154 | 1 | 372 | 0.9738 | 0.7966 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.3 | The Amino Acid-Polyamine-Organocation (APC) Family |
ANNHBBDC_01059 | 2.A.66.1.31 | 98.7 | 6.2e-241 | 1 | 447 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
ANNHBBDC_01098 | 8.A.120.1.4 | 99.5 | 2.4e-121 | 1 | 217 | 1.0000 | 1.0000 | 8 | Accessory Factors Involved in Transport | 8.A | Auxiliary transport proteins | 8.A.120 | The Mitochondrial StAR-related Lipid Transfer Protein (StAR) Family |
ANNHBBDC_01163 | 1.A.33.1.2 | 70.1 | 5.3e-249 | 1 | 645 | 0.9985 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.33 | The Cation Channel-forming Heat Shock Protein-70 (Hsp70) Family |
ANNHBBDC_01231 | 2.A.14.1.1 | 72.6 | 5e-232 | 2 | 553 | 0.9982 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.14 | The Lactate Permease (LctP) Family |
ANNHBBDC_01314 | 3.A.2.1.1 | 75.4 | 5.9e-219 | 3 | 514 | 0.9961 | 6.4810 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
ANNHBBDC_01316 | 3.A.2.1.1 | 79.6 | 3.5e-210 | 1 | 464 | 1.0000 | 5.8228 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
ANNHBBDC_01350 | 2.A.1.3.85 | 98.7 | 5.3e-259 | 1 | 463 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
ANNHBBDC_01377 | 2.A.53.3.1 | 72.4 | 3.8e-199 | 1 | 492 | 0.9939 | 0.9898 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.53 | The Sulfate Permease (SulP) Family |
ANNHBBDC_01489 | 1.A.54.5.3 | 95.8 | 1.1e-158 | 1 | 286 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.54 | The Presenilin ER Ca2+ Leak Channel (Presenilin) Family |
ANNHBBDC_01554 | 2.A.66.1.21 | 100 | 2.1e-244 | 1 | 448 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
ANNHBBDC_01592 | 2.A.23.1.1 | 73.1 | 6.1e-169 | 1 | 424 | 0.9907 | 0.9703 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
ANNHBBDC_01677 | 3.A.1.122.18 | 99.8 | 0 | 1 | 664 | 1.0000 | 1.4921 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
ANNHBBDC_01678 | 3.A.1.122.18 | 100 | 1.4e-232 | 1 | 445 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
ANNHBBDC_01796 | 1.B.76.1.2 | 94.4 | 3.2e-141 | 1 | 251 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.76 | The Copper Resistance Putative Porin (CopB) Family |
ANNHBBDC_01921 | 2.A.6.2.29 | 100 | 1.3e-268 | 1 | 484 | 1.0000 | 1.1635 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_01922 | 2.A.6.2.29 | 99.9 | 0 | 1 | 1058 | 1.0000 | 2.5433 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_01923 | 2.A.6.2.29 | 100 | 5.7e-220 | 1 | 416 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_02074 | 1.C.1.2.4 | 97.9 | 2.9e-204 | 1 | 467 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.C | Pore-Forming Toxins (Proteins and Peptides) | 1.C.1 | The Channel-forming Colicin (Colicin) Family |
ANNHBBDC_02095 | 1.B.63.1.1 | 76.4 | 2e-108 | 1 | 249 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.63 | The Imipenum resistance-associated porin, CarO (CarO) Family |
ANNHBBDC_02162 | 2.A.23.1.8 | 80.1 | 1e-198 | 1 | 463 | 0.9978 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
ANNHBBDC_02365 | 1.B.39.3.1 | 99.2 | 1.8e-203 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.39 | The Bacterial Porin, OmpW (OmpW) Family |
ANNHBBDC_02466 | 2.A.6.2.44 | 99.4 | 1.5e-261 | 1 | 482 | 1.0000 | 1.1872 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_02467 | 2.A.6.2.44 | 99.5 | 0 | 1 | 1059 | 1.0000 | 2.6084 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_02468 | 2.A.6.2.44 | 99.5 | 1.4e-218 | 1 | 406 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_02476 | 3.A.1.3.29 | 72.7 | 1e-102 | 6 | 258 | 0.9806 | 1.1096 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
ANNHBBDC_02477 | 2.A.7.1.11 | 100 | 1.6e-52 | 1 | 109 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
ANNHBBDC_02496 | 2.A.23.1.10 | 73.3 | 1.8e-171 | 3 | 429 | 0.9447 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
ANNHBBDC_02571 | 1.B.11.6.1 | 99.3 | 0 | 1 | 832 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.11 | The Outer Membrane Fimbrial Usher Porin (FUP) Family |
ANNHBBDC_02592 | 2.A.23.1.3 | 72.4 | 1.4e-160 | 14 | 426 | 0.9560 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
ANNHBBDC_02826 | 2.A.117.1.1 | 98.6 | 4.5e-76 | 1 | 144 | 1.0000 | 0.8045 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.117 | The Chlorhexadine Exporter (CHX) Family |
ANNHBBDC_02832 | 2.A.1.3.43 | 99 | 1.6e-261 | 1 | 492 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
ANNHBBDC_03023 | 2.A.7.21.5 | 73.9 | 5.4e-53 | 1 | 142 | 0.9861 | 0.9404 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
ANNHBBDC_03024 | 2.A.7.21.5 | 76.2 | 6.5e-57 | 5 | 151 | 0.9671 | 0.9735 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
ANNHBBDC_03117 | 9.B.153.4.2 | 97.8 | 1.2e-185 | 1 | 315 | 1.0000 | 1.0000 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.153 | The Putative Beta-Barrel Porin/Alpha Amylase or Phenol_MetA-deg (BBP/AA) Family |
ANNHBBDC_03163 | 2.A.6.2.32 | 76.9 | 0 | 1 | 1019 | 0.9893 | 6.8851 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
ANNHBBDC_03205 | 2.A.51.1.4 | 70.8 | 1.2e-183 | 9 | 447 | 0.9777 | 0.9648 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.51 | The Chromate Ion Transporter (CHR) Family |
ANNHBBDC_03285 | 2.A.1.3.63 | 98.3 | 2.5e-264 | 1 | 479 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
ANNHBBDC_03383 | 2.A.21.2.3 | 71.7 | 1e-199 | 1 | 495 | 0.9980 | 0.9783 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.21 | The Solute:Sodium Symporter (SSS) Family |
ANNHBBDC_03428 | 3.A.1.3.22 | 75.5 | 1.8e-104 | 3 | 243 | 0.9757 | 0.9877 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
ANNHBBDC_03493 | 2.A.70.1.2 | 79.3 | 4.1e-104 | 9 | 254 | 0.9685 | 1.5092 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
ANNHBBDC_03494 | 2.A.70.1.2 | 71.2 | 2.1e-38 | 1 | 125 | 0.9058 | 0.7669 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
ANNHBBDC_03518 | 1.S.8.1.1 | 74.4 | 8.2e-131 | 5 | 308 | 0.9806 | 0.9967 | 1 | Channels/Pores | 1.S | Bacterial Micro/NanoCompartment Shell Protein Pores | 1.S.8 | The Bacterial/Archaeal Nanocompartment Encapsulin Shell Protein3 (BANC-SP3) Family |
ANNHBBDC_03585 | 2.A.1.15.4 | 89.9 | 8.5e-208 | 10 | 416 | 0.9784 | 0.9831 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
ANNHBBDC_03657 | 3.A.23.4.1 | 98.1 | 6.3e-148 | 1 | 268 | 1.0000 | 0.7363 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03658 | 3.A.23.4.1 | 98.9 | 5.2e-259 | 1 | 454 | 1.0000 | 1.2473 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03659 | 3.A.23.4.1 | 95.6 | 6.1e-202 | 1 | 364 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03660 | 3.A.23.4.1 | 97.1 | 0 | 1 | 892 | 1.0000 | 2.4533 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03664 | 3.A.23.4.1 | 97.1 | 0 | 28 | 1274 | 0.9788 | 3.4396 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03666 | 3.A.23.4.1 | 95.8 | 2.8e-185 | 1 | 332 | 1.0000 | 0.9121 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03667 | 3.A.23.4.1 | 98.2 | 0 | 1 | 603 | 1.0000 | 1.6566 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03670 | 3.A.23.4.1 | 99.4 | 2.7e-285 | 1 | 493 | 1.0000 | 1.3544 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
ANNHBBDC_03833 | 5.B.1.3.2 | 99.4 | 3.2e-208 | 1 | 353 | 1.0000 | 1.0000 | 5 | Transmembrane Electron Carriers | 5.B | Transmembrane 1-electron transfer carriers | 5.B.1 | The Phagocyte (gp91<sup>phox</sup>) NADPH Oxidase Family |
ANNHBBDC_03840 | 2.A.46.1.1 | 79.9 | 2.9e-173 | 1 | 388 | 0.9773 | 0.9848 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.46 | The Benzoate:H+ Symporter (BenE) Family |
ANNHBBDC_03842 | 1.B.25.1.38 | 92.9 | 3.3e-236 | 1 | 420 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
ANNHBBDC_03856 | 1.B.6.13.5 | 99.4 | 3.6e-255 | 1 | 471 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
ANNHBBDC_03967 | 1.B.25.1.6 | 85 | 1.2e-220 | 1 | 426 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
ANNHBBDC_03968 | 2.A.1.15.6 | 85.4 | 1e-211 | 1 | 446 | 0.9955 | 0.9955 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_00060 | 1.B.40.2.6 | 76.9 | 0 | 1 | 1820 | 0.8930 | 0.9616 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.40 | The Autotransporter-2 (AT-2) Family |
BIMJNAPA_00174 | 9.B.143.1.2 | 76.3 | 9e-90 | 1 | 232 | 0.9872 | 0.9788 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.143 | The 6 TMS DUF1275/Pf06912 (DUF1275) Family |
BIMJNAPA_00187 | 1.B.25.3.1 | 96.9 | 7.3e-266 | 1 | 448 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
BIMJNAPA_00203 | 2.A.1.3.62 | 99.8 | 1.1e-286 | 1 | 507 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_00216 | 3.A.15.2.1 | 84 | 9.9e-165 | 11 | 354 | 0.9690 | 2.4397 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.15 | The Outer Membrane Protein Secreting Main Terminal Branch (MTB) Family |
BIMJNAPA_00368 | 9.B.8.2.5 | 96.2 | 8.8e-267 | 1 | 506 | 0.8533 | 0.9806 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.8 | The DUF2157 (DUF2157) Family |
BIMJNAPA_00477 | 2.A.6.3.3 | 99.8 | 0 | 22 | 1032 | 0.9797 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_00500 | 1.B.6.1.24 | 99.4 | 1.9e-200 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
BIMJNAPA_00605 | 1.B.6.1.26 | 100 | 7.5e-88 | 1 | 159 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
BIMJNAPA_00775 | 2.A.1.2.51 | 99.2 | 3.3e-192 | 1 | 362 | 0.9972 | 0.8765 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_00939 | 1.A.1.28.6 | 99.6 | 2.3e-122 | 1 | 230 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.1 | The Voltage-gated Ion Channel (VIC) Superfamily |
BIMJNAPA_00958 | 1.B.1.2.1 | 99.6 | 1.6e-145 | 1 | 255 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.1 | The General Bacterial Porin (GBP) Family |
BIMJNAPA_01044 | 2.A.3.1.9 | 71.2 | 5e-154 | 1 | 372 | 0.9738 | 0.7966 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.3 | The Amino Acid-Polyamine-Organocation (APC) Family |
BIMJNAPA_01059 | 2.A.66.1.31 | 98.7 | 6.2e-241 | 1 | 447 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
BIMJNAPA_01098 | 8.A.120.1.4 | 99.5 | 2.4e-121 | 1 | 217 | 1.0000 | 1.0000 | 8 | Accessory Factors Involved in Transport | 8.A | Auxiliary transport proteins | 8.A.120 | The Mitochondrial StAR-related Lipid Transfer Protein (StAR) Family |
BIMJNAPA_01163 | 1.A.33.1.2 | 70.1 | 5.3e-249 | 1 | 645 | 0.9985 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.33 | The Cation Channel-forming Heat Shock Protein-70 (Hsp70) Family |
BIMJNAPA_01231 | 2.A.14.1.1 | 72.6 | 5e-232 | 2 | 553 | 0.9982 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.14 | The Lactate Permease (LctP) Family |
BIMJNAPA_01314 | 3.A.2.1.1 | 75.4 | 5.9e-219 | 3 | 514 | 0.9961 | 6.4810 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
BIMJNAPA_01316 | 3.A.2.1.1 | 79.6 | 3.5e-210 | 1 | 464 | 1.0000 | 5.8228 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.2 | The H+- or Na+-translocating F-type, V-type and A-type ATPase (F-ATPase) Superfamily |
BIMJNAPA_01350 | 2.A.1.3.85 | 98.7 | 5.3e-259 | 1 | 463 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_01377 | 2.A.53.3.1 | 72.4 | 3.8e-199 | 1 | 492 | 0.9939 | 0.9898 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.53 | The Sulfate Permease (SulP) Family |
BIMJNAPA_01489 | 1.A.54.5.3 | 95.8 | 1.1e-158 | 1 | 286 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.54 | The Presenilin ER Ca2+ Leak Channel (Presenilin) Family |
BIMJNAPA_01554 | 2.A.66.1.21 | 100 | 2.1e-244 | 1 | 448 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.66 | The Multidrug/Oligosaccharidyl-lipid/Polysaccharide (MOP) Flippase Superfamily |
BIMJNAPA_01592 | 2.A.23.1.1 | 73.1 | 6.1e-169 | 1 | 424 | 0.9907 | 0.9703 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
BIMJNAPA_01677 | 3.A.1.122.18 | 99.8 | 0 | 1 | 664 | 1.0000 | 1.4921 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
BIMJNAPA_01678 | 3.A.1.122.18 | 100 | 1.4e-232 | 1 | 445 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
BIMJNAPA_01796 | 1.B.76.1.2 | 94.4 | 3.2e-141 | 1 | 251 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.76 | The Copper Resistance Putative Porin (CopB) Family |
BIMJNAPA_01921 | 2.A.6.2.29 | 100 | 1.3e-268 | 1 | 484 | 1.0000 | 1.1635 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_01922 | 2.A.6.2.29 | 99.9 | 0 | 1 | 1058 | 1.0000 | 2.5433 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_01923 | 2.A.6.2.29 | 100 | 5.7e-220 | 1 | 416 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_02074 | 1.C.1.2.4 | 97.9 | 2.9e-204 | 1 | 467 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.C | Pore-Forming Toxins (Proteins and Peptides) | 1.C.1 | The Channel-forming Colicin (Colicin) Family |
BIMJNAPA_02095 | 1.B.63.1.1 | 76.4 | 2e-108 | 1 | 249 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.63 | The Imipenum resistance-associated porin, CarO (CarO) Family |
BIMJNAPA_02162 | 2.A.23.1.8 | 80.1 | 1e-198 | 1 | 463 | 0.9978 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
BIMJNAPA_02365 | 1.B.39.3.1 | 99.2 | 1.8e-203 | 1 | 356 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.39 | The Bacterial Porin, OmpW (OmpW) Family |
BIMJNAPA_02466 | 2.A.6.2.44 | 99.4 | 1.5e-261 | 1 | 482 | 1.0000 | 1.1872 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_02467 | 2.A.6.2.44 | 99.5 | 0 | 1 | 1059 | 1.0000 | 2.6084 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_02468 | 2.A.6.2.44 | 99.5 | 1.4e-218 | 1 | 406 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_02476 | 3.A.1.3.29 | 72.7 | 1e-102 | 6 | 258 | 0.9806 | 1.1096 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
BIMJNAPA_02477 | 2.A.7.1.11 | 100 | 1.6e-52 | 1 | 109 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
BIMJNAPA_02496 | 2.A.23.1.10 | 73.3 | 1.8e-171 | 3 | 429 | 0.9447 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
BIMJNAPA_02571 | 1.B.11.6.1 | 99.3 | 0 | 1 | 832 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.11 | The Outer Membrane Fimbrial Usher Porin (FUP) Family |
BIMJNAPA_02592 | 2.A.23.1.3 | 72.4 | 1.4e-160 | 14 | 426 | 0.9560 | 0.9302 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.23 | The Dicarboxylate/Amino Acid:Cation (Na+ or H+) Symporter (DAACS) Family |
BIMJNAPA_02826 | 2.A.117.1.1 | 98.6 | 4.5e-76 | 1 | 144 | 1.0000 | 0.8045 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.117 | The Chlorhexadine Exporter (CHX) Family |
BIMJNAPA_02832 | 2.A.1.3.43 | 99 | 1.6e-261 | 1 | 492 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_03023 | 2.A.7.21.5 | 73.9 | 5.4e-53 | 1 | 142 | 0.9861 | 0.9404 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
BIMJNAPA_03024 | 2.A.7.21.5 | 76.2 | 6.5e-57 | 5 | 151 | 0.9671 | 0.9735 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
BIMJNAPA_03117 | 9.B.153.4.2 | 97.8 | 1.2e-185 | 1 | 315 | 1.0000 | 1.0000 | 9 | Incompletely Characterized Transport Systems | 9.B | Putative transport proteins | 9.B.153 | The Putative Beta-Barrel Porin/Alpha Amylase or Phenol_MetA-deg (BBP/AA) Family |
BIMJNAPA_03163 | 2.A.6.2.32 | 76.9 | 0 | 1 | 1019 | 0.9893 | 6.8851 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.6 | The Resistance-Nodulation-Cell Division (RND) Superfamily |
BIMJNAPA_03205 | 2.A.51.1.4 | 70.8 | 1.2e-183 | 9 | 447 | 0.9777 | 0.9648 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.51 | The Chromate Ion Transporter (CHR) Family |
BIMJNAPA_03285 | 2.A.1.3.63 | 98.3 | 2.5e-264 | 1 | 479 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_03383 | 2.A.21.2.3 | 71.7 | 1e-199 | 1 | 495 | 0.9980 | 0.9783 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.21 | The Solute:Sodium Symporter (SSS) Family |
BIMJNAPA_03428 | 3.A.1.3.22 | 75.5 | 1.8e-104 | 3 | 243 | 0.9757 | 0.9877 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.1 | The ATP-binding Cassette (ABC) Superfamily |
BIMJNAPA_03493 | 2.A.70.1.2 | 79.3 | 4.1e-104 | 9 | 254 | 0.9685 | 1.5092 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
BIMJNAPA_03494 | 2.A.70.1.2 | 71.2 | 2.1e-38 | 1 | 125 | 0.9058 | 0.7669 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.70 | The Malonate:Na+ Symporter (MSS) Family |
BIMJNAPA_03518 | 1.S.8.1.1 | 74.4 | 8.2e-131 | 5 | 308 | 0.9806 | 0.9967 | 1 | Channels/Pores | 1.S | Bacterial Micro/NanoCompartment Shell Protein Pores | 1.S.8 | The Bacterial/Archaeal Nanocompartment Encapsulin Shell Protein3 (BANC-SP3) Family |
BIMJNAPA_03585 | 2.A.1.15.4 | 89.9 | 8.5e-208 | 10 | 416 | 0.9784 | 0.9831 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
BIMJNAPA_03657 | 3.A.23.4.1 | 98.1 | 6.3e-148 | 1 | 268 | 1.0000 | 0.7363 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03658 | 3.A.23.4.1 | 98.9 | 5.2e-259 | 1 | 454 | 1.0000 | 1.2473 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03659 | 3.A.23.4.1 | 95.6 | 6.1e-202 | 1 | 364 | 1.0000 | 1.0000 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03660 | 3.A.23.4.1 | 97.1 | 0 | 1 | 892 | 1.0000 | 2.4533 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03664 | 3.A.23.4.1 | 97.1 | 0 | 28 | 1274 | 0.9788 | 3.4396 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03666 | 3.A.23.4.1 | 95.8 | 2.8e-185 | 1 | 332 | 1.0000 | 0.9121 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03667 | 3.A.23.4.1 | 98.2 | 0 | 1 | 603 | 1.0000 | 1.6566 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03670 | 3.A.23.4.1 | 99.4 | 2.7e-285 | 1 | 493 | 1.0000 | 1.3544 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.23 | The Type VI Symbiosis/Virulence Secretory System (T6SS) Family |
BIMJNAPA_03833 | 5.B.1.3.2 | 99.4 | 3.2e-208 | 1 | 353 | 1.0000 | 1.0000 | 5 | Transmembrane Electron Carriers | 5.B | Transmembrane 1-electron transfer carriers | 5.B.1 | The Phagocyte (gp91<sup>phox</sup>) NADPH Oxidase Family |
BIMJNAPA_03840 | 2.A.46.1.1 | 79.9 | 2.9e-173 | 1 | 388 | 0.9773 | 0.9848 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.46 | The Benzoate:H+ Symporter (BenE) Family |
BIMJNAPA_03842 | 1.B.25.1.38 | 92.9 | 3.3e-236 | 1 | 420 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
BIMJNAPA_03856 | 1.B.6.13.5 | 99.4 | 3.6e-255 | 1 | 471 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.6 | The OmpA-OmpF Porin (OOP) Family |
BIMJNAPA_03967 | 1.B.25.1.6 | 85 | 1.2e-220 | 1 | 426 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.B | β-Barrel Porins | 1.B.25 | The Outer Membrane Porin (Opr) Family |
BIMJNAPA_03968 | 2.A.1.15.6 | 85.4 | 1e-211 | 1 | 446 | 0.9955 | 0.9955 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |